Vontier (VNT) 10-Q 30 Oct 20 2020 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 25, 2020	Oct. 23, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 25, 2020
Document Transition Report	false
Entity File Number	001-39483
Entity Registrant Name	Vontier Corporation
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	84-2783455
Entity Address, Address Line One	5420 Wade Park Boulevard
Entity Address, Address Line Two	Suite 206
Entity Address, City or Town	Raleigh
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	27607
City Area Code	984
Local Phone Number	247-8308
Title of 12(b) Security	Common stock, par value $0.0001 per share
Trading Symbol	VNT
Security Exchange Name	NYSE
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		168,378,725
Amendment Flag	false
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001786842
Current Fiscal Year End Date	--12-31

Combined Condensed Balance Shee

Combined Condensed Balance Sheets - USD ($) $ in Millions	Sep. 25, 2020	Dec. 31, 2019
Current assets:
Accounts receivable less allowance for credit losses of $41.1 million and $32.2 million at September 25, 2020 and December 31, 2019, respectively	$ 431.1	$ 490.6
Inventories:
Finished goods	87.8	95.8
Work in process	18.4	25.2
Raw materials	111.4	103.1
Total inventories	217.6	224.1
Prepaid expenses and other current assets	107.6	110.5
Total current assets	756.3	825.2
Property, plant and equipment, net of accumulated depreciation of $234.7 million and $225.3 million at September 25, 2020 and December 31, 2019, respectively	94.7	101.9
Operating lease right-of-use assets	39.9	37.8
Long-term financing receivables less allowance for credit losses of $36.0 million and $24.1 million at September 25, 2020 and December 31, 2019, respectively	243.5	259
Other assets	159.7	172.9
Goodwill	1,058.7	1,157.8
Other intangible assets, net	250.9	274.3
Total assets	2,603.7	2,828.9
Current liabilities:
Total short-term borrowings	12.9	16.8
Trade accounts payable	356.3	318.6
Current operating lease liabilities	11.1	12.8
Accrued expenses and other current liabilities	325.1	319.3
Total current liabilities	705.4	667.5
Long-term operating lease liabilities	29.5	25.2
Other long-term liabilities	281.4	295.5
Long-term debt	0	24.6
Equity:
Preferred stock -- 15,000,000 authorized shares; no par value; and none issued and outstanding	0	0
Common stock -- 1,985,000,000 and 1,000 shares authorized at September 25, 2020 and December 31, 2019, respectively; $.0001 par value; and 1,000 shares issued and outstanding at September 25, 2020 and December 31, 2019	0	0
Net Parent investment	1,445.8	1,662.5
Accumulated other comprehensive income	137.3	148.7
Total stockholders’ equity	1,583.1	1,811.2
Noncontrolling interests	4.3	4.9
Total equity	1,587.4	1,816.1
Total liabilities and equity	$ 2,603.7	$ 2,828.9

Combined Condensed Balance Sh_2

Combined Condensed Balance Sheets (Parenthetical) - USD ($) $ in Millions	Sep. 25, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Accounts receivable, allowance for credit losses	$ 41.1	$ 32.2
Accumulated depreciation	234.7	225.3
Financing receivable, allowance for credit losses	$ 36	$ 24.1
Preferred stock, authorized (in shares)	15,000,000	15,000,000
Preferred stock, par value (in dollars per share)	$ 0	$ 0
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, authorized (in shares)	1,985,000,000	1,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, issued (in shares)	1,000	1,000
Common stock, outstanding (in shares)	1,000	1,000

Combined Condensed Statements o

Combined Condensed Statements of Earnings - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 25, 2020	Sep. 27, 2019	Sep. 25, 2020	Sep. 27, 2019
Sales:
Sales	$ 746.7	$ 714.4	$ 1,889.6	$ 2,028.8
Cost of sales:
Cost of sales	(415.4)	(406.4)	(1,064.2)	(1,163.6)
Gross profit	331.3	308	825.4	865.2
Operating costs:
Selling, general and administrative expenses	(121.1)	(118.3)	(356)	(362.9)
Research and development expenses	(31.6)	(34.8)	(93.7)	(102)
Impairment of goodwill	0	0	(85.3)	0
Operating profit	178.6	154.9	290.4	400.3
Non-operating income (expense):
Interest (expense) income, net	(0.2)	2.9	(0.8)	5.1
Other non-operating expenses	(0.1)	(0.2)	(0.4)	(0.6)
Earnings before income taxes	178.3	157.6	289.2	404.8
Income tax expense	(37.3)	(36.6)	(84)	(94.5)
Net earnings	$ 141	$ 121	$ 205.2	$ 310.3
Net earnings per share:
Basic and diluted (in dollars per share)	$ 0.84	$ 0.72	$ 1.22	$ 1.84
Average common stock and common equivalent shares outstanding:
Basic and diluted (in shares)	168.4	168.4	168.4	168.4
Products
Sales:
Sales	$ 686	$ 639.7	$ 1,713.9	$ 1,813
Cost of sales:
Cost of sales	(367)	(359.9)	(926)	(988.5)
Services
Sales:
Sales	60.7	74.7	175.7	215.8
Cost of sales:
Cost of sales	$ (48.4)	$ (46.5)	$ (138.2)	$ (175.1)

Combined Condensed Statements_2

Combined Condensed Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 25, 2020	Sep. 27, 2019	Sep. 25, 2020	Sep. 27, 2019
Statement of Comprehensive Income [Abstract]
Net earnings	$ 141	$ 121	$ 205.2	$ 310.3
Other comprehensive income (loss), net of income taxes:
Foreign currency translation adjustments	14.3	(15.8)	(13.3)	(10.1)
Other adjustments	0.1	0.1	1.9	0.3
Net current period other comprehensive income (loss), net of income taxes	14.4	(15.7)	(11.4)	(9.8)
Comprehensive income	$ 155.4	$ 105.3	$ 193.8	$ 300.5

Combined Condensed Statements_3

Combined Condensed Statements of Changes in Equity - USD ($) $ in Millions	Total	Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss)Cumulative Effect, Period of Adoption, Adjusted Balance	Net Parent Investment	Net Parent InvestmentCumulative Effect, Period of Adoption, Adjustment	Net Parent InvestmentCumulative Effect, Period of Adoption, Adjusted Balance	Noncontrolling Interests	Noncontrolling InterestsCumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance at Dec. 31, 2018		$ 126.3		$ 1,663.5			$ 3.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings for the period				76.4
Net transfers to Parent				(47.1)
Other comprehensive income (loss)		2.6
Stock-based compensation expense				2.8
Change in noncontrolling interests							0.4
Ending balance at Mar. 29, 2019		128.9		1,695.6			3.5
Beginning balance at Dec. 31, 2018		126.3		1,663.5			3.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings for the period	$ 310.3
Other comprehensive income (loss)	(9.8)
Ending balance at Sep. 27, 2019		116.5		1,554.7			4.2
Beginning balance at Mar. 29, 2019		128.9		1,695.6			3.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings for the period				112.9
Net transfers to Parent				(110.5)
Other comprehensive income (loss)		3.3
Stock-based compensation expense				3.4
Ending balance at Jun. 28, 2019		132.2		1,701.4			3.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings for the period	121			121
Net transfers to Parent				(127.1)
Non-cash settlement of net related-party borrowings				(144.2)
Other comprehensive income (loss)	(15.7)	(15.7)
Stock-based compensation expense				3.6
Change in noncontrolling interests							0.7
Ending balance at Sep. 27, 2019		116.5		1,554.7			4.2
Beginning balance at Dec. 31, 2019	1,816.1	148.7	$ 148.7	1,662.5	$ (16.9)	$ 1,645.6	4.9	$ 4.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings for the period				(4.2)
Net transfers to Parent				(13.1)
Non-cash settlement of net related-party borrowings				(1)
Other comprehensive income (loss)		(44.5)
Stock-based compensation expense				3.6
Change in noncontrolling interests							(1.1)
Ending balance at Mar. 27, 2020		104.2		1,630.9			3.8
Beginning balance at Dec. 31, 2019	1,816.1	148.7	$ 148.7	1,662.5	$ (16.9)	$ 1,645.6	4.9	$ 4.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings for the period	205.2
Other comprehensive income (loss)	(11.4)
Ending balance at Sep. 25, 2020	1,587.4	137.3		1,445.8			4.3
Beginning balance at Mar. 27, 2020		104.2		1,630.9			3.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings for the period				68.4
Net transfers to Parent				(170.1)
Non-cash settlement of net related-party borrowings				0.2
Other comprehensive income (loss)		18.7
Stock-based compensation expense				6
Change in noncontrolling interests							0.5
Ending balance at Jun. 26, 2020		122.9		1,535.4			4.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings for the period	141			141
Net transfers to Parent				(236.7)
Other comprehensive income (loss)	14.4	14.4
Stock-based compensation expense				6.1
Ending balance at Sep. 25, 2020	$ 1,587.4	$ 137.3		$ 1,445.8			$ 4.3

Combined Condensed Statements_4

Combined Condensed Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 25, 2020	Sep. 27, 2019
Cash flows from operating activities:
Net earnings	$ 205.2	$ 310.3
Non-cash items:
Depreciation	37.8	38.4
Amortization	21.8	24.1
Stock-based compensation expense	15.7	9.8
Impairment of goodwill	85.3	0
Change in deferred income taxes	(8.6)	(1.5)
Change in trade accounts receivable, net	(51.2)	(104.6)
Change in long-term financing receivables, net	104.4	99.3
Change in inventories	4.4	2.6
Change in trade accounts payable	37.9	(19.7)
Change in prepaid expenses and other assets	6.3	0.6
Change in accrued expenses and other liabilities	21.6	(37)
Net cash provided by operating activities	480.6	322.3
Cash flows from investing activities:
Cash paid for investments	(9.5)	(4.1)
Payments for additions to property, plant and equipment	(27.3)	(27)
Proceeds from sale of property	0.5	0
Net cash used in investing activities	(36.3)	(31.1)
Cash flows from financing activities:
Net repayments of related-party borrowings	(23.4)	(0.3)
Net (repayments of) proceeds from short-term borrowings	(3.5)	3.6
Net transfers to Parent	(419.9)	(284.7)
Other financing activities	(0.7)	(5.4)
Net cash used in financing activities	(447.5)	(286.8)
Effect of exchange rate changes on cash and equivalents	3.2	(4.4)
Net change in cash and equivalents	0	0
Beginning balance of cash and equivalents	0	0
Ending balance of cash and equivalents	$ 0	$ 0

Business Overview and Basis of

Business Overview and Basis of Presentation	9 Months Ended
	Sep. 25, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business Overview and Basis of Presentation	NOTE 1. BUSINESS OVERVIEW AND BASIS OF PRESENTATION Nature of Business Vontier Corporation (“Vontier”, the “Company”, “we”, “us” or “our”) offers critical technical equipment, components, software and services for manufacturing, repair, and servicing in the mobility infrastructure industry worldwide. The Company supplies a wide range of mobility technologies and diagnostics and repair technologies solutions spanning advanced environmental sensors, fueling equipment, field payment, hardware, remote management and workflow software, vehicle tracking and fleet management software-as-service solutions, professional vehicle mechanics’ and technicians’ equipment and traffic priority control systems. The Company markets its products and services to retail and commercial fueling operators, commercial vehicle repair businesses, municipal governments and public safety entities and fleet owners/operators on a global basis. Vontier operates through one reportable segment comprised of two operating segments: (i) mobility technologies, which is a leading worldwide provider of solutions and services focused on fuel dispensing, remote fuel management, point-of-sale and payment systems, environmental compliance, vehicle tracking and fleet management and traffic management, and (ii) diagnostics and repair technologies, which manufactures and distributes vehicle repair tools, toolboxes and automotive diagnostic equipment and software and a full line of wheel-service equipment. Given the interrelationships of the products, technologies and customers and the resulting similar long-term economic characteristics, we meet the aggregation criteria and have combined our two operating segments into a single reportable segment. Historically, these businesses had operated as part of Fortive Corporation’s Industrial Technologies reportable segment. On October 9, 2020, Fortive Corporation (“Fortive” or “Parent”) completed the separation of Fortive’s Industrial Technologies businesses through a pro rata distribution of 80.1% of the outstanding common stock of Vontier to Fortive’s stockholders (the “Separation”). Refer to “Note 13. Subsequent Events” for additional information regarding the Separation. In addition, on September 28, 2020, the 1,000 shares of Vontier common stock held by Fortive were recapitalized into 168,378,946 shares of Vontier common stock held by Fortive. All per share amounts in the Combined Condensed Statement of Earnings have been retroactively adjusted to give effect to this recapitalization. Basis of Presentation Vontier has historically operated as part of Fortive and not as a stand-alone company. The financial statements have been derived from Fortive’s historical accounting records and are presented on a carved-out basis. All revenues and costs as well as assets and liabilities directly associated with the business activity of the Company are included as components of the financial statements. The financial statements also include allocations of certain general, administrative, sales and marketing expenses and cost of sales from Fortive’s corporate office and from other Fortive businesses to us and allocations of related assets, liabilities, and Parent investment, as applicable. The allocations have been determined on a reasonable basis; however, the amounts are not necessarily representative of the amounts that would have been reflected in the financial statements had we been an entity that operated independently of Fortive. Refer to additional discussion of related party allocations in “Note 11. Related Party Transactions.” As part of Fortive, we were dependent upon Fortive for all of our working capital and financing requirements as Fortive uses a centralized approach to cash management and financing of its operations. Financial transactions with Fortive relating to the Company are accounted for through the Net Parent investment account. Accordingly, none of Fortive’s cash and equivalents or debt at the corporate level has been assigned to us in the accompanying Combined Condensed Financial Statements. Net Parent investment, which includes retained earnings, represents Fortive’s interest in the recorded net assets of Vontier. All significant transactions between Vontier and Fortive have been included in the accompanying Combined Condensed Financial Statements for the three and nine months ended September 25, 2020 and September 27, 2019. Transactions with Fortive are reflected in the accompanying Combined Condensed Statements of Changes in Equity as “Net transfers to Parent” and included in the accompanying Combined Condensed Balance Sheets within “Net Parent investment.” As part of Fortive, we engaged in intercompany financing transactions (“Related-Party Borrowings”). Transactions between Vontier and Fortive have been included in the accompanying Combined Condensed Financial Statements for all periods presented. These transactions were settled prior to the Separation. All other intercompany accounts and transactions between the operations comprising Vontier have been eliminated in the accompanying Combined Condensed Financial Statements for the three and nine months ended September 25, 2020 and September 27, 2019. Unaudited Interim Financial Information The interim Combined Condensed Financial Statements include the accounts of the Company. These Combined Condensed Financial Statements are prepared in conformity with U.S. generally accepted accounting principles, or “GAAP”, for the preparation of carved-out Combined Condensed Financial Statements and are unaudited. In the opinion of Company’s management, all adjustments of a normal recurring nature necessary for a fair presentation have been reflected. Certain financial information that is normally included in annual financial statements prepared in accordance with GAAP, but that is not required for interim reporting purposes, has been omitted. The accompanying interim Combined Condensed Financial Statements and the related notes should be read in conjunction with the Company’s Combined Financial Statements and related notes included in the Company’s Form 10-12B/A filed on September 21, 2020. Reclassification A reclassification of certain prior year amounts has been made to conform to current year presentation reflecting a reclassification of $3.5 million from Long-term financing receivables less allowance for credit losses to Other assets.

Financing Receivables

Financing Receivables	9 Months Ended
	Sep. 25, 2020
Credit Loss [Abstract]
Financing Receivables	NOTE 2. FINANCING RECEIVABLES The Company’s financing receivables are comprised of commercial purchase security agreements with the Company’s end customers (“PSAs”) and commercial loans to the Company’s franchisees (“Franchisee Notes”). Financing receivables are generally secured by the underlying tools and equipment financed. Revenues associated with the Company’s interest income related to financing receivables are recognized to approximate a constant effective yield over the contract term. Accrued interest is included in Accounts receivable less allowance for credit losses and is insignificant as of September 25, 2020 and December 31, 2019. The components of financing receivables with payments due in less than twelve months that are recorded in Accounts receivable less allowance for credit losses on the Combined Condensed Balance Sheets were as follows: ($ in millions) September 25, 2020 December 31, 2019 Gross current financing receivables: PSAs $ 97.7 $ 104.6 Franchisee Notes 14.8 15.7 Current financing receivables, gross $ 112.5 $ 120.3 Allowance for credit losses: PSAs $ 15.0 $ 10.0 Franchisee Notes 7.1 7.2 Total allowance for credit losses 22.1 17.2 Total current financing receivables, net $ 90.4 $ 103.1 Net current financing receivables: PSAs, net $ 82.7 $ 94.6 Franchisee Notes, net 7.7 8.5 Total current financing receivables, net $ 90.4 $ 103.1 The components of financing receivables with payments due beyond one year were as follows: ($ in millions) September 25, 2020 December 31, 2019 Gross long-term financing receivables: PSAs $ 221.3 $ 222.9 Franchisee Notes 58.2 60.2 Long-term financing receivables, gross $ 279.5 $ 283.1 Allowance for credit losses: PSAs $ 30.4 $ 19.4 Franchisee Notes 5.6 4.7 Total allowance for credit losses 36.0 24.1 Total long-term financing receivables, net $ 243.5 $ 259.0 Net long-term financing receivables: PSAs, net $ 190.9 $ 203.5 Franchisee Notes, net 52.6 55.5 Total long-term financing receivables, net $ 243.5 $ 259.0 Net deferred origination costs were insignificant at September 25, 2020 and December 31, 2019. At September 25, 2020 we had a net unamortized discount on our financing receivables of $18.6 million. The net unamortized discount at December 31, 2019 was $19.3 million. It is the Company’s general practice to not engage in contract or loan modifications of existing arrangements for troubled debt restructurings. In limited instances, the Company may modify certain impaired receivables with customers in bankruptcy or other legal proceedings, or in the event of significant natural disasters. Restructured financing receivables as of September 25, 2020 and December 31, 2019 were insignificant. Credit score and distributor tenure are the primary indicators of credit quality for the Company’s financing receivables. Depending on the contract, payments for financing receivables are due on a monthly or weekly basis. Weekly payments are converted into a monthly equivalent for purposes of calculating delinquency. Delinquencies are assessed at the end of each month following the monthly equivalent due date and are considered delinquent once past due. The amortized cost basis of PSAs and Franchisee Notes by origination year as of September 25, 2020, is as follows: ($ in millions) 2020 2019 2018 2017 2016 Prior Total PSAs Credit Score: Less than 400 $ 14.1 $ 12.0 $ 5.6 $ 2.6 $ 0.8 $ 0.4 $ 35.5 400-599 20.6 15.9 8.6 3.8 1.3 0.6 50.8 600-799 42.2 30.5 16.1 7.6 2.8 0.7 99.9 800+ 59.6 40.6 21.2 8.6 2.4 0.4 132.8 Total PSAs $ 136.5 $ 99.0 $ 51.5 $ 22.6 $ 7.3 $ 2.1 $ 319.0 Franchisee Notes Active distributors $ 15.9 $ 22.4 $ 10.0 $ 6.5 $ 3.4 $ 4.5 $ 62.7 Separated distributors 0.1 1.1 1.6 1.5 2.0 4.0 10.3 Total Franchisee Notes $ 16.0 $ 23.5 $ 11.6 $ 8.0 $ 5.4 $ 8.5 $ 73.0 Past Due PSAs are considered past due when a contractual payment has not been made. If a customer is making payments on its account, interest will continue to accrue. The table below sets forth the aging of the Company’s PSA balances: ($ in millions) 30-59 days past due 60-90 days past due Greater than 90 days past due Total past due Total not considered past due Total Greater than 90 days past due and accruing interest September 25, 2020 $ 3.1 $ 1.6 $ 6.7 $ 11.4 $ 307.6 $ 319.0 $ 6.7 December 31, 2019 3.7 1.9 7.2 12.8 314.7 327.5 7.2 Franchisee Notes are considered past due when payments have not been made for 21 days after the due date. Past due Franchisee Notes (where the franchisee had not yet separated) were insignificant as of September 25, 2020 and December 31, 2019. Uncollectable Status PSAs are deemed uncollectable and written-off when they are both contractually delinquent and no payment has been received for 180 days. Franchisee Notes are deemed uncollectable and written-off after a distributor separates and no payments have been received for one year. The Company stops accruing interest and other fees associated with financing receivables when (i) a customer is placed in uncollectable status and repossession efforts have begun; (ii) upon receipt of notification of bankruptcy; (iii) upon notification of the death of a customer; or (iv) other instances in which management concludes collectability is not reasonably assured. Adoption of New Accounting Standard In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which amends the impairment model by requiring entities to use a forward-looking approach, based on expected losses, to estimate credit losses on certain types of financial instruments, including financing and trade accounts receivables. On January 1, 2020, we adopted ASU 2016-13 $16.9 million . Results for reporting periods beginning January 1, 2020 reflect the adoption of ASU 2016-13, while prior period amounts were not adjusted and continue to be reported in accordance with our historical accounting practices. Prior to the adoption of ASU 2016-13 on January 1, 2020, we recognized an allowance for incurred losses when they were probable based on many quantitative and qualitative factors, including delinquency. After the adoption of ASU 2016-13, we estimate our allowance to reflect expected credit losses over the remaining contractual life of the asset. We pool assets with similar risk characteristics for this measurement based on attributes which includes asset type, duration, and/or credit risk rating. The future expected losses of each pool are estimated based on numerous quantitative and qualitative factors reflecting management’s estimate of collectability over the remaining contractual life of the pooled assets, including: • portfolio duration; • historical, current, and forecasted future loss experience by asset type; • historical, current, and forecasted delinquency and write-off trends; • historical, current, and forecasted economic conditions; and • historical, current, and forecasted credit risk. Expected credit losses of the assets originated during the three and nine months ended September 25, 2020, as well as changes to expected losses during the same period, are recognized in earnings for the periods ended September 25, 2020. As a result of the adoption of ASU 2016-13, we have updated our significant accounting policy related to trade accounts and financing receivables and allowances for credit losses from what was previously disclosed in its audited financial statements for the year ended December 31, 2019 as follows: All trade accounts and financing receivables are reported in the accompanying Combined Condensed Balance Sheets adjusted for any write-offs and net of allowances for credit losses. The allowances for credit losses represent management’s best estimate of the credit losses expected from our trade accounts and financing receivable portfolios over the life of the underlying assets. Determination of the allowances requires management to exercise judgment about the severity of credit losses, which includes judgments regarding the risk profile of each underlying receivable and expectations regarding the impact of current and future economic conditions on the creditworthiness of its customers. We regularly perform detailed reviews of its portfolios to evaluate the collectability of receivables based on a combination of past, current, and future financial and qualitative factors that may affect customers’ ability to pay, including customers’ financial condition, collateral, debt-servicing ability, payment experience, credit bureau information, and economic conditions. In circumstances where we are aware of a specific customer’s inability to meet its financial obligations, a specific reserve is recorded against amounts due to reduce the recognized receivable to the amount reasonably expected to be collected. Additions to the allowances are charged to current period earnings, amounts determined to be uncollectible are charged directly against the allowances, while amounts recovered on accounts that were previously written off increase the allowances. Recent deterioration in overall global economic conditions and worldwide capital markets as a result of the COVID-19 pandemic may negatively impact our customers’ ability to pay and, as a result, may increase the difficulty in collecting trade accounts and financing receivables. We did not realize notable increases in loss rates and delinquencies during the three and nine months ended September 25, 2020, and given the nature of our portfolio of receivables, our historical experience during times of challenging economic conditions, and our forecasted future impact of COVID-19 on our customers’ ability to pay, we did not record material provisions for credit losses as a result of the COVID-19 pandemic during the three and nine months ended September 25, 2020. If the financial condition of our customers were to deteriorate beyond our current estimates, resulting in an impairment of their ability to make payments, we would be required to write off additional receivable balances, which would adversely impact our net earnings and financial condition. Allowance for Credit Losses related to Financing Receivables The Company calculates the allowance for credit losses considering several factors, including the aging of its financing receivables, historical credit loss and portfolio delinquency experience and current economic conditions. The Company also evaluates financing receivables with identified exposures, such as customer defaults, bankruptcy or other events that make it unlikely it will recover the amounts owed to it. In calculating such reserves, the Company evaluates expected cash flows, including estimated proceeds from disposition of collateral, and calculates an estimate of the potential loss and the probability of loss. When a loss is considered probable on an individual financing receivable, a specific reserve is recorded. The following is a rollforward of the PSAs and Franchisee Notes components of the Company’s allowances for credit losses related to financing receivables as of September 25, 2020 and December 31, 2019: September 25, 2020 December 31, 2019 ($ in millions) PSAs Franchisee Notes Total PSAs Franchisee Notes Total Balance at beginning of year $ 29.4 $ 11.9 $ 41.3 $ 29.6 $ 14.2 $ 43.8 Transition adjustment 17.5 1.0 18.5 — — — Provision for doubtful accounts 22.1 5.0 27.1 26.4 4.5 30.9 Write-offs (25.7) (5.3) (31.0) (28.2) (7.2) (35.4) Recoveries of amounts previously charged off 2.1 0.1 2.2 1.6 0.4 2.0 Balances at end of period $ 45.4 $ 12.7 $ 58.1 $ 29.4 $ 11.9 $ 41.3 The ending balance as of September 25, 2020 of $58.1 million is included in the Combined Condensed Balance Sheets in Accounts receivable less allowance for credit losses and Long-term financing receivables less allowance for credit losses in the amounts of $22.1 million and $36.0 million, respectively. The ending balance as of December 31, 2019 of $41.3 million is included in the Combined Condensed Balance Sheets in Accounts receivable less allowance for credit losses and Long-term financing receivables less allowance for credit losses in the amounts of $17.2 million and $24.1 million, respectively. Allowance for Credit Losses related to Trade Accounts Receivables The following is a rollforward of the allowance for credit losses related to the Company’s trade accounts receivables (excluding financing receivables) and the Company’s trade accounts receivable cost basis as of September 25, 2020: ($ in millions) Cost basis of trade accounts receivable at September 25, 2020 $ 359.7 Allowance for credit losses balance at December 31, 2019 15.0 Adoption of new accounting standard 3.6 Provision for credit losses 6.6 Write-offs (6.3) FX and other 0.1 Allowance for credit losses balance at September 25, 2020 19.0 Net trade accounts receivable balance at September 25, 2020 $ 340.7

Goodwill

Goodwill	9 Months Ended
	Sep. 25, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	NOTE 3. GOODWILL The following is a rollforward of our carrying value of goodwill ($ in millions): Balance, December 31, 2019 $ 1,157.8 Impairment charge (85.3) FX translation & other (13.8) Balance, September 25, 2020 $ 1,058.7 Impairment Charge We test goodwill for impairment annually in the fourth quarter of each year and may review goodwill in interim periods if certain events occur or circumstances change. Based on our most recent annual impairment assessment, we concluded that the goodwill for our five reporting units was not impaired as of December 31, 2019. The results of our fourth quarter 2019 goodwill impairment testing indicated the excess of the estimated fair value over the carrying value (expressed as a percentage of carrying value) of our Telematics reporting unit was approximately 5%, and as such, management continued to monitor the performance of Telematics during the first quarter of 2020. In connection with management’s updated forecast for the Telematics reporting unit that indicated a decline in sales and operating profit to levels lower than previously forecasted, due in large part to the impacts of the COVID-19 pandemic, we performed a quantitative impairment assessment over the Telematics reporting unit on March 27, 2020. We estimated the fair value of the Telematics reporting unit through an income approach, using the discounted cash flow method. The income approach was based on projected future (debt-free) cash flows that were discounted to present value and assumed a terminal growth value. The discount rate was based on the reporting unit’s weighted average cost of capital, taking into account market participant assumptions. Management’s revenue and profitability forecasts used in the valuation considered recent and historical performance of the reporting unit, strategic initiatives, industry trends, and the current and future expectations of the macroeconomic environment. Assumptions used in the valuation were similar to those that would be used by market participants performing independent valuations of this reporting unit. Key assumptions developed by management and used in the quantitative analysis included the following: • Near-term revenue declines in 2020 with later-term improvements over the projection period; • Improved profitability over the projection period, trending consistent with revenues; and • Market-based discount rates. We did not consider the market approach in our fair value calculation given the near-term uncertainty in the market data and forecasts of the guideline companies upon which the approach relies. As a result of the interim impairment testing performed, we concluded that the estimated fair value of our Telematics reporting unit was less than its carrying value as of March 27, 2020, and recorded a non-cash goodwill impairment charge of $85.3 million during the three months ended March 27, 2020 to reduce the carrying value of goodwill to $238.8 million. The charge is included in operating results. The impairment testing of goodwill utilized significant unobservable inputs (Level 3 in the fair value hierarchy) to determine the estimated fair value. The factors used in our impairment analysis are inherently subject to uncertainty, particularly in light of the deterioration in overall global economic conditions and capital markets due to COVID-19. While we believe we made reasonable estimates and assumptions to calculate the fair value of the Telematics reporting unit, alternative interpretations of the qualitative inputs considered may have resulted in different conclusions regarding the size of the impairment, and it is possible our conclusions could change in future periods. The results of our 2019 impairment testing indicated our four other reporting units had fair values that were significantly in excess of their carrying values. We evaluated the impact of the deterioration in overall global economic conditions as a result of the COVID-19 pandemic, including changes in forecasts for each reporting unit, and determined no triggering events had occurred, other than as noted above. There can be no assurance the estimates and assumptions used in Vontier’s goodwill impairment testing performed will prove to be accurate predictions of the future. Specifically, variations in Vontier’s assumptions related to business performance and execution of planned growth strategies and the discount rate could impact future conclusions. A future impairment charge for goodwill could have a material effect on Vontier’s combined balance sheets and statements of earnings.

Financing

Financing	9 Months Ended
	Sep. 25, 2020
Debt Disclosure [Abstract]
Financing	NOTE 4. FINANCING The carrying values of the components of our long-term debt were as follows: ($ in millions) September 25, 2020 December 31, 2019 Short-term borrowings: 7.00% Credit Facility due in January 2020 $ — $ 12.6 6.95% Credit Facility due October 2020 12.2 — Other short-term borrowings and bank overdrafts 0.7 4.2 Total short-term borrowings $ 12.9 $ 16.8 Long-term debt: Related-party loans with Fortive entities — 24.6 Long-term debt $ — $ 24.6 Debt issuance costs that have been netted against the aggregate principal amounts of the components of debt in the table above are insignificant. Given the nature of the Company’s borrowings, the carrying value approximates fair value at both September 25, 2020 and December 31, 2019. Short-term Borrowings We have entered into short-term borrowing arrangements with various banks to facilitate short-term cash flow requirements in certain countries. Additionally, certain of our businesses participated in Fortive’s cash pooling arrangements. At September 25, 2020 and December 31, 2019, certain of our businesses were in a cash overdraft position, and such overdrafts are included in Short-term borrowings on the Combined Condensed Balance Sheets. Third party debt held by Fortive and the related interest expense was not allocated to us. The interest rate associated with the Company’s other short-term borrowings and bank overdrafts as of September 25, 2020 and December 31, 2019 was approximately 7.2% and 9.0%, respectively. Interest payments associated with the above borrowings were insignificant for the nine months ended September 25, 2020 and September 27, 2019. On October 3, 2020, the 6.95% credit facility with Citibank, N.A. was renewed for $10.9 million at 5.95% with a maturity date of November 3, 2020. The 6.70% Credit Facility due in July 2020 was repaid on July 3, 2020. Long-term Debt As part of Fortive, we engaged in intercompany financing transactions. Transactions between Fortive and the Company have been included in Long-term debt on the Combined Condensed Balance Sheets as of December 31, 2019. As of December 31, 2019, these loans had an average interest rate of approximately 1.0%. These transactions were settled during the nine months ended September 25, 2020. Refer to “Note 11. Related Party Transactions” for additional information regarding the related-party loans with Fortive entities. Additionally, refer to “Note 13. Subsequent Events” for additional information regarding financing transactions entered into subsequent to period end.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	9 Months Ended
	Sep. 25, 2020
Equity [Abstract]
Accumulated Other Comprehensive Income (Loss)	NOTE 5. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) Foreign currency translation adjustments are generally not adjusted for income taxes as they relate to indefinite investments in non-U.S. subsidiaries. The changes in accumulated other comprehensive income (loss) by component are summarized below: ($ in millions) Foreign Other adjustments (b) Total For the Three Months Ended September 25, 2020: Balance, June 26, 2020 $ 126.1 $ (3.2) $ 122.9 Other comprehensive income (loss) before reclassifications, net of income taxes 14.3 — 14.3 Amounts reclassified from accumulated other comprehensive income: Increase — 0.1 0.1 Amounts reclassified from accumulated other comprehensive income, net of income taxes — 0.1 (a) 0.1 Net current period other comprehensive income (loss), net of income taxes 14.3 0.1 14.4 Balance, September 25, 2020 $ 140.4 $ (3.1) $ 137.3 For the Three Months Ended September 27, 2019: Balance, June 28, 2019 $ 137.0 $ (4.8) $ 132.2 Other comprehensive income (loss) before reclassifications, net of income taxes (15.8) (0.2) (16.0) Amounts reclassified from accumulated other comprehensive income: Increase — 0.4 0.4 Income tax impact — (0.1) (0.1) Amounts reclassified from accumulated other comprehensive income, net of income taxes — 0.3 (a) 0.3 Net current period other comprehensive income (loss), net of income taxes (15.8) 0.1 (15.7) Balance, September 27, 2019 $ 121.2 $ (4.7) $ 116.5 (a) This accumulated other comprehensive income component is included in the computation of net periodic pension cost. (b) Includes balances relating to defined benefit plans, supplemental executive retirement plans and other postretirement employee benefit plans. ($ in millions) Foreign Other adjustments (b) Total For the Nine Months Ended September 25, 2020: Balance, December 31, 2019 $ 153.7 $ (5.0) $ 148.7 Other comprehensive income (loss) before reclassifications, net of income taxes (13.3) — (13.3) Amounts reclassified from accumulated other comprehensive income: Increase — 2.0 2.0 Income tax impact — (0.1) (0.1) Amounts reclassified from accumulated other comprehensive income, net of income taxes — 1.9 (a) 1.9 Net current period other comprehensive income (loss), net of income taxes (13.3) 1.9 (11.4) Balance, September 25, 2020 $ 140.4 $ (3.1) $ 137.3 For the Nine Months Ended September 27, 2019: Balance, December 31, 2018 $ 131.3 $ (5.0) $ 126.3 Other comprehensive income (loss) before reclassifications, net of income taxes (10.1) (0.2) (10.3) Amounts reclassified from accumulated other comprehensive income: Increase — 0.6 0.6 Income tax impact — (0.1) (0.1) Amounts reclassified from accumulated other comprehensive income, net of income taxes — 0.5 (a) 0.5 Net current period other comprehensive income (loss), net of income taxes (10.1) 0.3 (9.8) Balance, September 27, 2019 $ 121.2 $ (4.7) $ 116.5 (a) This accumulated other comprehensive income component is included in the computation of net periodic pension cost. (b) Includes balances relating to defined benefit plans, supplemental executive retirement plans and other postretirement employee benefit plans.

Sales

Sales	9 Months Ended
	Sep. 25, 2020
Revenue from Contract with Customer [Abstract]
Sales	NOTE 6. SALES Revenue is recognized when control of promised products or services is transferred to customers in an amount that reflects the consideration we expect to be entitled to in exchange for those products or services. Contract Assets In certain circumstances, the Company records contract assets which include unbilled amounts typically resulting from sales under contracts when revenue recognized exceeds the amount billed to the customer, and right to payment is not only subject to the passage of time. Contract assets were $11.7 million and $12.8 million as of September 25, 2020 and December 31, 2019, respectively. Contract Costs The Company incurs direct incremental costs to obtain certain contracts, typically sales-related commissions and costs associated with assets used by our customers as part of certain service arrangements. Deferred sales-related commissions are generally not capitalized as the amortization period is one year or less, and the Company elected to use the practical expedient to expense these sales commissions as incurred. As of September 25, 2020 the Company had $81.1 million in net revenue-related capitalized contract costs primarily related to assets used by our customers in certain software contracts, which are recorded in Prepaid expenses and other current assets and Other assets in the accompanying Combined Condensed Balance Sheets. Contract costs were $95.2 million as of December 31, 2019. These assets have estimated useful lives between 3 and 5 years. Impairment losses recognized on our revenue-related contract assets were insignificant in the nine months ended September 25, 2020. Contract Liabilities The Company’s contract liabilities consist of deferred revenue generally related to post contract support (“PCS”) and extended warranty sales. In these arrangements, the Company generally receives up-front payment and recognizes revenue over the support term of the contracts. Deferred revenue is classified as current or noncurrent based on the timing of when revenue is expected to be recognized. The noncurrent portion of deferred revenue is included in Other long-term liabilities in the accompanying Combined Condensed Balance Sheets. The Company’s contract liabilities consisted of the following: ($ in millions) September 25, 2020 December 31, 2019 Deferred revenue - current $ 85.1 $ 87.0 Deferred revenue - noncurrent 57.9 63.2 Total contract liabilities $ 143.0 $ 150.2 During the three and nine months ended September 25, 2020, we recognized $31.1 million and $84.8 million of revenue related to the Company’s contract liabilities at December 31, 2019. The change in contract liabilities from December 31, 2019 to September 25, 2020 was primarily due to the timing of cash receipts and sales of PCS and extended warranty services. Remaining Performance Obligations Remaining performance obligations represent the transaction price of firm, noncancelable orders and the annual contract value for software as a service contracts with expected customer delivery dates beyond one year from September 25, 2020 for which work has not been performed. The Company has excluded performance obligations with an original expected duration of one year or less. Performance obligations as of September 25, 2020 are $386.0 million, the majority of which are related to the annual contract value for software as a service contracts. The Company expects approximately 35 percent of the remaining performance obligations will be fulfilled within the next two years, 65 percent within the next three years, and substantially all within four years. Disaggregation of Revenue The Company disaggregates revenue from contracts with customers by sales of products and services, geographic location, major product group, and end market, as it best depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. Disaggregation of revenue for the three months ended September 25, 2020 and September 27, 2019 were as follows: ($ in millions) September 25, 2020 September 27, 2019 Sales: Sales of products $ 686.0 $ 639.7 Sales of services 60.7 74.7 Total $ 746.7 $ 714.4 Geographic: North America (a) $ 539.9 $ 494.0 Western Europe 63.7 65.8 High growth markets 111.7 124.7 Rest of world 31.4 29.9 Total $ 746.7 $ 714.4 Major Product Group: Mobility technologies $ 578.6 $ 551.6 Diagnostics and repair technologies 168.1 162.8 Total $ 746.7 $ 714.4 (a) Includes sales in the United States of $525.5 million and $477.5 million for the three months ended September 25, 2020 and September 27, 2019, respectively. Disaggregation of revenue for the nine months ended September 25, 2020 and September 27, 2019 were as follows: ($ in millions) September 25, 2020 September 27, 2019 Sales: Sales of products $ 1,713.9 $ 1,813.0 Sales of services 175.7 215.8 Total $ 1,889.6 $ 2,028.8 Geographic: North America (a) $ 1,348.3 $ 1,369.5 Western Europe 176.6 204.8 High growth markets 279.5 364.6 Rest of World 85.2 89.9 Total $ 1,889.6 $ 2,028.8 Major Product Group: Mobility technologies $ 1,441.6 $ 1,542.8 Diagnostics and repair technologies 448.0 486.0 Total $ 1,889.6 $ 2,028.8 (a) Includes sales in the United States of $1,309.2 million and $1,321.3 million for the nine months ended September 25, 2020 and September 27, 2019, respectively.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 25, 2020
Income Tax Disclosure [Abstract]
Income Taxes	NOTE 7. INCOME TAXES Our effective tax rate for the three and nine months ended September 25, 2020 was 20.9% and 29.0%, respectively, as compared to 23.2% and 23.3% for the three and nine months ended September 27, 2019, respectively. The year-over-year decrease in the effective tax rate for the three months ended September 25, 2020 as compared to the comparable period in the prior year was primarily due to the favorable impact of a higher mix of income in jurisdictions with lower tax rates than the U.S. federal statutory rate of 21%. The year-over-year increase in the effective tax rate for the nine months ended September 25, 2020 as compared to the comparable period in the prior year was primarily due to a non-deductible goodwill impairment recognized in Q1. This was partially offset by favorable impacts of a higher mix of income in jurisdictions with lower tax rates than the U.S. federal statutory rate of 21% and increases in favorable impacts of certain federal and international tax benefits. Our effective tax rate for both periods in 2020 and 2019 differs from the U.S. federal statutory rate of 21% due primarily to the impact of the Tax Cuts and Jobs Act (“TCJA”), certain U.S. federal permanent differences, the impact of credits and deductions provided by law, and current year earnings outside the United States that are indefinitely reinvested and taxed at rates lower than the U.S. federal statutory rate. Specific to the nine months ended September 25, 2020, our effective tax rate also differs from the U.S. federal statutory rate of 21% due to a non-deductible goodwill impairment in Q1.

Leases

Leases	9 Months Ended
	Sep. 25, 2020
Leases [Abstract]
Leases	NOTE 8. LEASES Operating lease cost was $5.3 million and $5.6 million for the three months ended September 25, 2020 and September 27, 2019, respectively. For the nine months ended September 25, 2020 and September 27, 2019, operating lease cost was $15.6 million and $16.8 million, respectively. During the nine months ended September 25, 2020 and September 27, 2019, cash paid for operating leases included in operating cash flows was $14.7 million and $16.9 million, respectively. Right-of-use assets obtained in exchange for operating lease obligations were $11.5 million and insignificant for the nine months ended September 25, 2020 and September 27, 2019, respectively.

Litigation and Contingencies

Litigation and Contingencies	9 Months Ended
	Sep. 25, 2020
Commitments and Contingencies Disclosure [Abstract]
Litigation and Contingencies	NOTE 9. LITIGATION AND CONTINGENCIES Warranty We generally accrue estimated warranty costs at the time of sale. In general, manufactured products are warrantied against defects in material and workmanship when properly used for their intended purpose, installed correctly, and appropriately maintained. Warranty period terms depend on the nature of the product and can extend up to the life of the product. The amount of the accrued warranty liability is determined based on historical information such as past experience, product failure rates or number of units repaired, estimated cost of material and labor, and in certain instances estimated property damage. The accrued warranty liability is reviewed on a quarterly basis and may be adjusted as additional information regarding expected warranty costs becomes known. The following is a rollforward of the Company’s accrued warranty liability ($ in millions): Balance, December 31, 2019 $ 57.4 Accruals for warranties issued during the period 27.7 Settlements made (32.3) Effect of foreign currency translation (0.1) Balance, September 25, 2020 $ 52.7 Litigation In accordance with accounting guidance, the Company records a liability in the Combined Condensed Financial Statements for loss contingencies when a loss is known or considered probable and the amount can be reasonably estimated. If the reasonable estimate of a known or probable loss is a range, and no amount within the range is a better estimate than any other, the minimum amount of the range is accrued. If a loss does not meet the known or probable level but is reasonably possible and a loss or range of loss can be reasonably estimated, the estimated loss or range of loss is disclosed. These reserves consist of specific reserves for individual claims and additional amounts for anticipated developments of these claims as well as for incurred but not yet reported claims. The specific reserves for individual known claims are quantified with the assistance of legal counsel and outside risk insurance professionals where appropriate. In addition, outside risk insurance professionals may assist in the determination of reserves for incurred but not yet reported claims through evaluation of our specific loss history, actual claims reported, and industry trends among statistical and other factors. Reserve estimates are adjusted as additional information regarding a claim becomes known. While we actively pursue financial recoveries from insurance providers, the Company does not recognize any recoveries until realized or until such time as a sustained pattern of collections is established related to historical matters of a similar nature and magnitude. If risk insurance reserves the Company has established are inadequate, we would be required to incur an expense equal to the amount of the loss incurred in excess of the reserves, which would adversely affect our net earnings. In connection with the recognition of liabilities for asbestos related matters, the Company records insurance recoveries that are deemed probable and estimable. In assessing the probability of insurance recovery, we make judgments concerning insurance coverage that we believe are reasonable and consistent with our historical dealings, our knowledge of any pertinent solvency issues surrounding insurers, and litigation and court rulings potentially impacting coverage. While the substantial majority of our insurance carriers are solvent, some of our individual carriers are insolvent, which has been considered in the analysis of probable recoveries. Projecting future events is subject to various uncertainties, including litigation and court rulings potentially impacting coverage, that could cause insurance recoveries on asbestos related liabilities to be higher or lower than those projected and recorded. Given the inherent uncertainty in making future projections, the Company reevaluates projections concerning the Company’s probable insurance recoveries considering any changes to the projected liabilities, the Company’s recovery experience or other relevant factors that may impact future insurance recoveries. We recorded gross liabilities associated with known and future expected asbestos claims of $51.0 million and $54.4 million as of September 25, 2020 and December 31, 2019, respectively. Known and future expected asbestos claims of $7.5 million and $5.6 million are included in Accrued expenses and other current liabilities on the Combined Condensed Balance Sheets as of September 25, 2020 and December 31, 2019, respectively. Known and future expected asbestos claims of $43.5 million and $48.8 million are included in Other long-term liabilities on the Combined Condensed Balance Sheets as of September 25, 2020 and December 31, 2019, respectively. We recorded the related projected insurance recoveries of $20.3 million and $24.9 million as of September 25, 2020 and December 31, 2019, respectively. Insurance recoveries in the accompanying Combined Condensed Balance Sheets as of September 25, 2020 include $3.9 million in Prepaid expenses and other current assets and $16.4 million in Other assets. Insurance recoveries in the accompanying Combined Condensed Balance Sheets as of December 31, 2019 include $3.9 million in Prepaid expenses and other current assets and $21.0 million in Other assets. Guarantees As of September 25, 2020 and December 31, 2019, we had guarantees consisting primarily of outstanding standby letters of credit, bank guarantees, and performance and bid bonds of approximately $69.3 million and $36.7 million, respectively. These guarantees have been provided in connection with certain arrangements with vendors, customers, financing counterparties, and governmental entities to secure our obligations and/or performance requirements related to specific transactions. We believe that if the obligations under these instruments were triggered, they would not have a material effect on our financial statements. On February 22, 2019, Fortive issued $1.4 billion in aggregate principal amount of its 0.875% Convertible Senior Notes due 2022 (the “Convertible Notes”). Certain of our subsidiaries had issued unconditional guarantees, on a joint and several unsecured basis, with respect to Fortive’s outstanding Convertible Notes and continued to guarantee such Convertible Notes until Fortive ceased to own a majority of the subsidiaries’ common stock. Following the distribution, on October 9, 2020, the unconditional guarantees provided by our subsidiaries were terminated.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 25, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements	NOTE 10. FAIR VALUE MEASUREMENTS Accounting standards define fair value based on an exit price model, establish a framework for measuring fair value where our assets and liabilities are required to be carried at fair value and provide for certain disclosures related to the valuation methods used within a valuation hierarchy as established within the accounting standards. This hierarchy prioritizes the inputs into three broad levels as follows: • Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. • Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, or other observable characteristics for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from, or corroborated by, observable market data through correlation. • Level 3 inputs are unobservable inputs based on our assumptions. The classification of a financial asset or liability within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Below is a summary of financial liabilities that are measured at fair value on a recurring basis: ($ in millions) Quoted Prices Significant Other Significant Total September 25, 2020 Deferred compensation liabilities $ — $ 15.6 $ — $ 15.6 December 31, 2019 Deferred compensation liabilities $ — $ 14.7 $ — $ 14.7 Certain management employees of the Company participate in Fortive’s nonqualified deferred compensation programs, which permit such employees to defer a portion of their compensation, on a pretax basis, until after their termination of employment. All amounts deferred under such plans are unfunded, unsecured obligations and are allocated to us. These amounts are presented as a component of compensation and benefits accruals included in Other long-term liabilities in the accompanying Combined Condensed Balance Sheets. Participants may choose among alternative earnings rates for the amounts they defer, which are primarily based on investment options within Fortive’s defined contribution plans for the benefit of U.S. employees (except that the earnings rates for amounts contributed unilaterally by Fortive are entirely based on changes in the value of Fortive common stock). Changes in the deferred compensation liability under these programs are recognized based on changes in the fair value of the participants’ accounts, which are based on the applicable earnings rates. Fair Value of Financial Instruments Refer to “Note 4. Financing” for information related to the fair value of the Company’s borrowings. Other Investments The Company holds minority interest in Tritium Holdings Pty, Ltd (“Tritium”) of $49.0 million, which is recorded in Other assets on the Combined Condensed Balance Sheets at cost. The Company has elected to use the measurement alternative for equity investments without readily determinable fair values and evaluate this investment for indicators of impairment quarterly. The Company did not identify events or changes in circumstances that may have a significant effect on the fair value of the investment during the three and nine months ended September 25, 2020. Nonrecurring Fair Value Measurements Certain non-financial assets, primarily property, plant, and equipment, goodwill, and intangible assets, are not required to be measured at fair value on a recurring basis and are reported at their carrying value. However, these assets are required to be assessed for impairment whenever events or circumstances indicate that their carrying value may not be fully recoverable, and at least annually for goodwill and indefinite-lived intangible assets other than as noted in “Note 3. Goodwill.” On March 27, 2020, we evaluated our Telematics reporting unit for impairment and recorded an impairment of goodwill of $85.3 million to adjust the carrying value of the reporting unit to the estimated fair value. Refer to “Note 3. Goodwill” for additional information regarding the inputs and methodology used to estimate the fair value. During the three months ended September 25, 2020, we evaluated the impact of the volatility in overall global economic conditions as a result of the

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 25, 2020
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 11. RELATED PARTY TRANSACTIONS Allocations of Expenses Prior to the Separation The Company has historically operated as part of Fortive and not as a stand-alone company. Accordingly, certain shared costs have been allocated to the Company by Fortive, and are reflected as expenses in these financial statements. Management considers the allocation methodologies used to be reasonable and appropriate reflections of the related expenses attributable to the Company for purposes of the carve-out financial statements; however, the expenses reflected in the accompanying Combined Condensed Financial Statements may not be indicative of the actual expenses that would have been incurred during the periods presented if the Company had operated as a separate stand-alone entity and the expenses that will be incurred in the future by the Company. Corporate Expenses Certain corporate overhead and other shared expenses incurred by Fortive and its subsidiaries have been allocated to the Company and are reflected in the accompanying Combined Condensed Statements of Earnings. These amounts include, but are not limited to, items such as general management and executive oversight, costs to support Fortive information technology infrastructure, facilities, compliance, human resources, and marketing, as well as legal functions and financial management and transaction processing, including public company reporting, consolidated tax filings, and tax planning, Fortive benefit plan administration, risk management and consolidated treasury services, certain employee benefits and incentives, and stock-based compensation administration. These costs are allocated using a methodology that management believes is reasonable for the item being allocated. Allocation methodologies include the Company’s relative share of revenues, headcount, or functional spend as a percentage of the total. Insurance Programs Administered by Fortive In addition to the corporate allocations noted above, the Company was allocated expenses related to certain insurance programs Fortive administers on behalf of the Company, including automobile liability, workers’ compensation, general liability, product liability, director’s and officer’s liability, cargo, and property insurance. These amounts are allocated using various methodologies, as described below. Included within the insurance cost allocation are amounts related to programs for which Fortive is self-insured up to a certain amount. For the self-insured component, costs are allocated to the Company based on its incurred claims. Fortive has premium-based policies that cover amounts in excess of the self-insured retentions. The Company is allocated a portion of the total insurance cost incurred by Fortive based on its pro-rata portion of Fortive’s total underlying exposure base. An estimated liability relating to the Company’s known and incurred but not reported claims has been allocated to the Company and reflected in the accompanying Combined Condensed Balance Sheets. Medical Insurance Programs Administered by Fortive In addition to the corporate allocations noted above, the Company was allocated expenses related to the medical insurance programs administered on behalf of the Company. These amounts were allocated using actual medical claims incurred during the period for the employees attributable to the Company. Deferred Compensation Program Administered by Fortive Certain employees of the Company participate in Fortive’s nonqualified deferred compensation programs, which permit officers, directors and certain management employees to defer a portion of their compensation, on a pretax basis, until their termination of employment. Participants may choose among alternative earnings rates for the amounts they defer, which are primarily based on investment options within Fortive’s 401(k) program (except that the earnings rates for amounts contributed unilaterally by the Company are entirely based on changes in the value of Fortive’s common stock). All amounts deferred under this plan are unfunded, unsecured obligations of the Company. The amount of related party expenses allocated to the Company from Fortive and its subsidiaries for the three and nine months ended September 25, 2020 and September 27, 2019, were as follows: Three Months Ended Nine Months Ended ($ in millions) September 25, 2020 September 27, 2019 September 25, 2020 September 27, 2019 Allocated corporate expenses $ 9.5 $ 6.7 $ 28.0 $ 20.2 Directly attributable expenses Insurance programs expenses 0.9 0.6 2.2 1.8 Medical insurance programs expenses 9.1 10.6 31.4 31.8 Deferred compensation program expenses 0.3 0.2 0.9 0.7 Total related party expenses $ 19.8 $ 18.1 $ 62.5 $ 54.5 Revenue and Other Transactions Entered into in the Ordinary Course of Business Certain of the Company’s revenue arrangements related to contracts entered into in the ordinary course of business with Fortive and its affiliates. The Company’s revenue from sales to Fortive and Fortive’s subsidiaries was insignificant during the three and nine months ended September 25, 2020 and September 27, 2019. The Company recorded purchases of approximately $4.0 million and $11.9 million from Fortive and Fortive’s subsidiaries during the three and nine months ended September 25, 2020, respectively, and $5.1 million and $11.5 million during the three and nine months ended September 27, 2019, respectively. Debt Financing As part of Fortive, the Company engaged in Related-Party Borrowings. Transactions between Fortive and the Company have been included in the accompanying Combined Condensed Financial Statements for all years presented. There were non-cash settlements of the related-party loan receivables balances that existed as of December 31, 2019 during the nine months ended September 25, 2020. Loans from Fortive to the Company have been recorded as Long-term debt in the accompanying Combined Condensed Balance Sheets. Related-party loans to Fortive entities were $24.6 million at December 31, 2019. These transactions were settled during the nine months ended September 25, 2020. Interest income (expense), net on related-party transactions was insignificant for the three and nine months ended September 25, 2020 and $3.1 million and $6.5 million for the three and nine months ended September 27, 2019, respectively.

Capitalization and Earnings Per

Capitalization and Earnings Per Share	9 Months Ended
	Sep. 25, 2020
Equity [Abstract]
Stockholders' Equity and Earnings Per Share	NOTE 12. CAPITALIZATION AND EARNINGS PER SHARE Capital Stock The Company’s authorized capital stock consists of 1,985,000,000 shares of common stock, par value $0.0001 per share, and 15,000,000 shares of preferred stock with no par value, all of which shares of preferred stock are undesignated. On August 5, 2019, we issued 1,000 shares of common stock to Fortive pursuant to Section 4(a)(2) of the Securities Act. We did not register the issuance of the issued shares under the Securities Act because the issuance did not constitute a public offering. On September 28, 2020, Vontier filed a certificate of amendment to the Certificate of Incorporation of Vontier (the “Split Amendment”) with the Secretary of State of the State of Delaware, which became effective as of such date. The Split Amendment effected a stock split whereby each share of Vontier Common Stock issued and outstanding immediately prior to the Split Amendment was converted into 168,378.946 shares in order to provide sufficient capitalization of Vontier to enable Fortive to complete the Distribution and retain a 19.9% interest in the remaining shares of common stock of Vontier. All per share amounts in the Combined Condensed Statements of Earnings have been retroactively adjusted to give effect to this recapitalization. On October 9, 2020, Fortive distributed 80.1% of Vontier’s outstanding common stock to its stockholders. For additional information regarding the distribution of shares, refer to “Note 13. Subsequent Events.” Each share of Vontier common stock entitles the holder to one vote on all matters to be voted upon by common stockholders. Vontier’s Board of Directors (the “Board”) is authorized to issue shares of preferred stock in one or more series and has discretion to determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, of each series of preferred stock. The Board’s authority to issue preferred stock with voting rights or conversion rights that, if exercised, could adversely affect the voting power of the holders of the common stock, could potentially discourage attempts by third parties to obtain control of Vontier through certain types of takeover practices. Earnings Per Share Basic earnings per share is calculated by dividing net earnings by the weighted average number of shares of common stock outstanding. Diluted earnings per share is similarly calculated, except that the calculation includes the dilutive effect of the assumed issuance of shares under stock-based compensation plans except where the inclusion of such shares would have an anti-dilutive impact. The total number of shares outstanding, including the impact of the Split Amendment, on September 25, 2020 was 168,378,946 which is being utilized for the calculation of both basic and diluted earnings per share for the three and nine months ended September 25, 2020 and September 27, 2019 as no Vontier common stock equivalents were outstanding prior to October 9, 2020.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 25, 2020
Subsequent Events [Abstract]
Subsequent Events	NOTE 13. SUBSEQUENT EVENTS On September 29, 2020 (the “Closing Date”), the Company entered into a credit agreement (the “Credit Agreement”) with a syndicate of banks, consisting of a three-year, $800.0 million senior unsecured delayed draw term loan facility (the “Three-Year Term Loans”), a two-year, $1.0 billion senior unsecured delayed draw term loan facility (the “Two-Year Term Loans” and together with the Three-Year Term Loans, the “Term Loans”) and a three-year, $750.0 million senior unsecured multi-currency revolving credit facility, including a $25.0 million sublimit for swingline loans and a $75.0 million sublimit for the issuance of letters of credit (the “Revolving Credit Facility” and, together with the Term Loans, the “Credit Facilities”). At the closing of the Credit Agreement, Vontier did not borrow any funds under the Credit Facilities. On October 9, 2020, the Company drew down the full $1.8 billion available under the Term Loans. The Company used the proceeds from the Term Loans to make payments to Fortive, with $1.6 billion used as part of the consideration for the contribution of certain assets and liabilities by the Company to Fortive in connection with the Separation and with $200.0 million used to fund cash balances remaining with the Company. Borrowings under the Credit Facilities bear interest as follows: (1) Eurocurrency Rate Loans (as defined in the Credit Agreement) bear interest at a variable rate equal to the London inter-bank offered rate plus a per annum margin of between 125 and 200 basis points, depending on (x) prior to receipt by Vontier of a long-term debt credit rating, Vontier’s Consolidated Leverage Ratio (as defined in the Credit Agreement) as of the last day of the immediately preceding fiscal quarter and (y) thereafter, Vontier’s long-term debt credit rating; and (2) Base Rate Loans (as defined in the Credit Agreement) bear interest at a variable rate equal to (a) the highest of (i) the Federal funds rate (as published by the Federal Reserve Bank of New York from time to time) plus 1/2 of 1%, (ii) Bank of America’s “prime rate” as publicly announced from time to time and (iii) the Eurocurrency Rate (as defined in the Credit Agreement) plus 1%, plus (b) a per annum margin of between 25 and 100 basis points, depending on (x) prior to receipt by Vontier of a long-term debt credit rating, Vontier’s Consolidated Leverage Ratio as of the last day of the immediately preceding fiscal quarter and (y) thereafter, Vontier’s long-term debt credit rating. In no event will Eurocurrency Rate Loans bear interest at a rate lower than 0% nor Base Rate Loans bear interest at a rate lower than 1%. The Credit Agreement requires Vontier to maintain a Consolidated Leverage Ratio of 3.75 to 1.00 or less; provided that, not more than two times after the Closing Date, the maximum Consolidated Leverage Ratio will be increased to 4.25 to 1.00 in connection with any permitted acquisition by Vontier occurring after the Closing Date with aggregate consideration (including, without duplication, the assumption or incurrence of Indebtedness in connection with such acquisition) equal to or in excess of $100,000,000, which such increase shall be applicable for the fiscal quarter in which such acquisition is consummated and the three consecutive test periods thereafter; provided that, there shall be at least one full fiscal quarter following the cessation of each such increase during which no such increase shall then be in effect. The Credit Agreement also requires Vontier to maintain a Consolidated Interest Coverage Ratio (as defined in the Credit Agreement) of at least 3.50 to 1.00. The Consolidated Leverage Ratio and Consolidated Interest Coverage Ratio will be tested at the end of each fiscal quarter commencing with the fiscal quarter ending December 31, 2020. Vontier used the proceeds from the Term Loans to fund a cash distribution to Fortive as partial consideration for the transfer of the assets and liabilities of Fortive’s Industrial Technologies business to Vontier. Vontier intends to use the Revolving Credit Facility for its ongoing working capital requirements after the Separation and for general corporate purposes. On October 9, 2020, Fortive completed the separation of Fortive’s Industrial Technologies businesses through a pro rata distribution of 80.1% of the outstanding common stock of Vontier to Fortive’s stockholders. To effect the Separation, Fortive distributed to its stockholders two shares of Vontier common stock for every five shares of Fortive common stock outstanding held on September 25, 2020, the record date for the distribution. Fortive currently plans to divest its retained share of Vontier of 19.9% after the spin-off in a tax-efficient manner no later than twelve months after the distribution date. As of the date of separation, Vontier had approximately $287.9 million in cash. The primary source of the cash on hand as of the date of separation was due to a transfer from Fortive as part of the separation agreement. Under the terms of the separation agreement, approximately $84.1 million is repayable by us to Fortive within 90 days of separation. In connection with the Separation, Vontier and Fortive entered into various agreements to effect the Separation and provide a framework for Vontier’s relationship with Fortive after the Separation, including a transition services agreement, an employee matters agreement, a tax matters agreement, an intellectual property matters agreement, a Fortive Business System (“FBS”) license agreement, and a stockholder’s and registration rights agreement. These agreements will govern the separation between Vontier and Fortive of the assets, employees, liabilities and obligations (including its investments, property and employee benefits and tax-related assets and liabilities) of Fortive and its subsidiaries attributable to periods prior to, at and after Vontier’s separation and will govern certain relationships between Vontier and Fortive after the Separation. In accordance with the provisions of the separation agreements, Fortive will retain responsibility for certain deferred compensation liabilities related to employees or former employees of Vontier Businesses whose employment terminated prior to October 9, 2020 or who did not legally transfer to Vontier. Following the Separation, accounts held by Vontier employees in Fortive deferred compensation programs referencing valuation of Fortive common stock were converted into accounts in Vontier deferred compensation programs referencing valuation of Vontier common stock, and with such account adjusted to maintain the economic value before and after the Separation date using the relative fair market value of the Fortive and Vontier common stock. The Company had no stock-based compensation plans as of September 25, 2020; however certain employees of the Company participated in Fortive's stock-based compensation plans, which provide for the grants of stock options and restricted stock units (“RSUs”) among other types of awards. The expense associated with the Company's employees who participated in the Fortive plans is allocated to the Company in the accompanying Combined Condensed Statements of Earnings. In connection with the Separation, the Company adopted the 2020 Stock Incentive Plan (the “Stock Plan”) and outstanding equity awards of Fortive held by Vontier employees were converted into or replaced with awards of Vontier common stock under the Stock Plan based on the “concentration method,” and as adjusted to maintain the economic value before and after the distribution date using the relative fair market value of the Fortive and Vontier common stock. Other than replacement equity awards of Vontier issued in replacement of Fortive's RSUs and stock options, the terms of the converted or replacement equity awards of Vontier (e.g., vesting date and expiration date) continued unchanged.

Business Overview and Basis o_2

Business Overview and Basis of Presentation (Policies)	9 Months Ended
	Sep. 25, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation Vontier has historically operated as part of Fortive and not as a stand-alone company. The financial statements have been derived from Fortive’s historical accounting records and are presented on a carved-out basis. All revenues and costs as well as assets and liabilities directly associated with the business activity of the Company are included as components of the financial statements. The financial statements also include allocations of certain general, administrative, sales and marketing expenses and cost of sales from Fortive’s corporate office and from other Fortive businesses to us and allocations of related assets, liabilities, and Parent investment, as applicable. The allocations have been determined on a reasonable basis; however, the amounts are not necessarily representative of the amounts that would have been reflected in the financial statements had we been an entity that operated independently of Fortive. Refer to additional discussion of related party allocations in “Note 11. Related Party Transactions.” As part of Fortive, we were dependent upon Fortive for all of our working capital and financing requirements as Fortive uses a centralized approach to cash management and financing of its operations. Financial transactions with Fortive relating to the Company are accounted for through the Net Parent investment account. Accordingly, none of Fortive’s cash and equivalents or debt at the corporate level has been assigned to us in the accompanying Combined Condensed Financial Statements. Net Parent investment, which includes retained earnings, represents Fortive’s interest in the recorded net assets of Vontier. All significant transactions between Vontier and Fortive have been included in the accompanying Combined Condensed Financial Statements for the three and nine months ended September 25, 2020 and September 27, 2019. Transactions with Fortive are reflected in the accompanying Combined Condensed Statements of Changes in Equity as “Net transfers to Parent” and included in the accompanying Combined Condensed Balance Sheets within “Net Parent investment.” As part of Fortive, we engaged in intercompany financing transactions (“Related-Party Borrowings”). Transactions between Vontier and Fortive have been included in the accompanying Combined Condensed Financial Statements for all periods
Adoption of New Accounting Standard	Adoption of New Accounting Standard In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which amends the impairment model by requiring entities to use a forward-looking approach, based on expected losses, to estimate credit losses on certain types of financial instruments, including financing and trade accounts receivables. On January 1, 2020, we adopted ASU 2016-13 $16.9 million . Results for reporting periods beginning January 1, 2020 reflect the adoption of ASU 2016-13, while prior period amounts were not adjusted and continue to be reported in accordance with our historical accounting practices. Prior to the adoption of ASU 2016-13 on January 1, 2020, we recognized an allowance for incurred losses when they were probable based on many quantitative and qualitative factors, including delinquency. After the adoption of ASU 2016-13, we estimate our allowance to reflect expected credit losses over the remaining contractual life of the asset. We pool assets with similar risk characteristics for this measurement based on attributes which includes asset type, duration, and/or credit risk rating. The future expected losses of each pool are estimated based on numerous quantitative and qualitative factors reflecting management’s estimate of collectability over the remaining contractual life of the pooled assets, including: • portfolio duration; • historical, current, and forecasted future loss experience by asset type; • historical, current, and forecasted delinquency and write-off trends; • historical, current, and forecasted economic conditions; and • historical, current, and forecasted credit risk. Expected credit losses of the assets originated during the three and nine months ended September 25, 2020, as well as changes to expected losses during the same period, are recognized in earnings for the periods ended September 25, 2020. As a result of the adoption of ASU 2016-13, we have updated our significant accounting policy related to trade accounts and financing receivables and allowances for credit losses from what was previously disclosed in its audited financial statements for the year ended December 31, 2019 as follows: All trade accounts and financing receivables are reported in the accompanying Combined Condensed Balance Sheets adjusted for any write-offs and net of allowances for credit losses. The allowances for credit losses represent management’s best estimate of the credit losses expected from our trade accounts and financing receivable portfolios over the life of the underlying assets. Determination of the allowances requires management to exercise judgment about the severity of credit losses, which includes judgments regarding the risk profile of each underlying receivable and expectations regarding the impact of current and future economic conditions on the creditworthiness of its customers. We regularly perform detailed reviews of its portfolios to evaluate the collectability of receivables based on a combination of past, current, and future financial and qualitative factors that may affect customers’ ability to pay, including customers’ financial condition, collateral, debt-servicing ability, payment experience, credit bureau information, and economic conditions. In circumstances where we are aware of a specific customer’s inability to meet its financial obligations, a specific reserve is recorded against amounts due to reduce the recognized receivable to the amount reasonably expected to be collected. Additions to the allowances are charged to current period earnings, amounts determined to be uncollectible are charged directly against the allowances, while amounts recovered on accounts that were previously written off increase the allowances. Recent deterioration in overall global economic conditions and worldwide capital markets as a result of the COVID-19 pandemic may negatively impact our customers’ ability to pay and, as a result, may increase the difficulty in collecting trade accounts and financing receivables. We did not realize notable increases in loss rates and delinquencies during the three and nine months ended September 25, 2020, and given the nature of our portfolio of receivables, our historical experience during times of challenging economic conditions, and our forecasted future impact of COVID-19 on our customers’ ability to pay, we did not record material provisions for credit losses as a result of the COVID-19 pandemic during the three and nine months ended September 25, 2020. If the financial condition of our customers were to deteriorate beyond our current estimates, resulting in an impairment of their ability to make payments, we would be required to write off additional receivable balances, which would adversely impact our net earnings and financial condition.
Reclassifications	Reclassification A reclassification of certain prior year amounts has been made to conform to current year presentation reflecting a reclassification of $3.5 million from Long-term financing receivables less allowance for credit losses to Other assets.
Sales	Revenue is recognized when control of promised products or services is transferred to customers in an amount that reflects the consideration we expect to be entitled to in exchange for those products or services. Contract Assets In certain circumstances, the Company records contract assets which include unbilled amounts typically resulting from sales under contracts when revenue recognized exceeds the amount billed to the customer, and right to payment is not only subject to the passage of time. Contract assets were $11.7 million and $12.8 million as of September 25, 2020 and December 31, 2019, respectively. Contract Costs The Company incurs direct incremental costs to obtain certain contracts, typically sales-related commissions and costs associated with assets used by our customers as part of certain service arrangements. Deferred sales-related commissions are generally not capitalized as the amortization period is one year or less, and the Company elected to use the practical expedient to expense these sales commissions as incurred. As of September 25, 2020 the Company had $81.1 million in net revenue-related capitalized contract costs primarily related to assets used by our customers in certain software contracts, which are recorded in Prepaid expenses and other current assets and Other assets in the accompanying Combined Condensed Balance Sheets. Contract costs were $95.2 million as of December 31, 2019. These assets have estimated useful lives between 3 and 5 years. Impairment losses recognized on our revenue-related contract assets were insignificant in the nine months ended September 25, 2020. Contract Liabilities The Company’s contract liabilities consist of deferred revenue generally related to post contract support (“PCS”) and extended warranty sales. In these arrangements, the Company generally receives up-front payment and recognizes revenue over the support term of the contracts. Deferred revenue is classified as current or noncurrent based on the timing of when revenue is expected to be recognized. The noncurrent portion of deferred revenue is included in Other long-term liabilities in the accompanying Combined Condensed Balance Sheets.

Revenue Recognition and Deferre

Revenue Recognition and Deferred Revenue (Policies)	9 Months Ended
	Sep. 25, 2020
Revenue Recognition and Deferred Revenue [Abstract]
Sales	Revenue is recognized when control of promised products or services is transferred to customers in an amount that reflects the consideration we expect to be entitled to in exchange for those products or services. Contract Assets In certain circumstances, the Company records contract assets which include unbilled amounts typically resulting from sales under contracts when revenue recognized exceeds the amount billed to the customer, and right to payment is not only subject to the passage of time. Contract assets were $11.7 million and $12.8 million as of September 25, 2020 and December 31, 2019, respectively. Contract Costs The Company incurs direct incremental costs to obtain certain contracts, typically sales-related commissions and costs associated with assets used by our customers as part of certain service arrangements. Deferred sales-related commissions are generally not capitalized as the amortization period is one year or less, and the Company elected to use the practical expedient to expense these sales commissions as incurred. As of September 25, 2020 the Company had $81.1 million in net revenue-related capitalized contract costs primarily related to assets used by our customers in certain software contracts, which are recorded in Prepaid expenses and other current assets and Other assets in the accompanying Combined Condensed Balance Sheets. Contract costs were $95.2 million as of December 31, 2019. These assets have estimated useful lives between 3 and 5 years. Impairment losses recognized on our revenue-related contract assets were insignificant in the nine months ended September 25, 2020. Contract Liabilities The Company’s contract liabilities consist of deferred revenue generally related to post contract support (“PCS”) and extended warranty sales. In these arrangements, the Company generally receives up-front payment and recognizes revenue over the support term of the contracts. Deferred revenue is classified as current or noncurrent based on the timing of when revenue is expected to be recognized. The noncurrent portion of deferred revenue is included in Other long-term liabilities in the accompanying Combined Condensed Balance Sheets.

Financing Receivables (Tables)

Financing Receivables (Tables)	9 Months Ended
	Sep. 25, 2020
Credit Loss [Abstract]
Schedule of Accounts, Notes, Loans and Financing Receivable	The components of financing receivables with payments due in less than twelve months that are recorded in Accounts receivable less allowance for credit losses on the Combined Condensed Balance Sheets were as follows: ($ in millions) September 25, 2020 December 31, 2019 Gross current financing receivables: PSAs $ 97.7 $ 104.6 Franchisee Notes 14.8 15.7 Current financing receivables, gross $ 112.5 $ 120.3 Allowance for credit losses: PSAs $ 15.0 $ 10.0 Franchisee Notes 7.1 7.2 Total allowance for credit losses 22.1 17.2 Total current financing receivables, net $ 90.4 $ 103.1 Net current financing receivables: PSAs, net $ 82.7 $ 94.6 Franchisee Notes, net 7.7 8.5 Total current financing receivables, net $ 90.4 $ 103.1 The components of financing receivables with payments due beyond one year were as follows: ($ in millions) September 25, 2020 December 31, 2019 Gross long-term financing receivables: PSAs $ 221.3 $ 222.9 Franchisee Notes 58.2 60.2 Long-term financing receivables, gross $ 279.5 $ 283.1 Allowance for credit losses: PSAs $ 30.4 $ 19.4 Franchisee Notes 5.6 4.7 Total allowance for credit losses 36.0 24.1 Total long-term financing receivables, net $ 243.5 $ 259.0 Net long-term financing receivables: PSAs, net $ 190.9 $ 203.5 Franchisee Notes, net 52.6 55.5 Total long-term financing receivables, net $ 243.5 $ 259.0
Financing Receivable Credit Quality Indicators	The amortized cost basis of PSAs and Franchisee Notes by origination year as of September 25, 2020, is as follows: ($ in millions) 2020 2019 2018 2017 2016 Prior Total PSAs Credit Score: Less than 400 $ 14.1 $ 12.0 $ 5.6 $ 2.6 $ 0.8 $ 0.4 $ 35.5 400-599 20.6 15.9 8.6 3.8 1.3 0.6 50.8 600-799 42.2 30.5 16.1 7.6 2.8 0.7 99.9 800+ 59.6 40.6 21.2 8.6 2.4 0.4 132.8 Total PSAs $ 136.5 $ 99.0 $ 51.5 $ 22.6 $ 7.3 $ 2.1 $ 319.0 Franchisee Notes Active distributors $ 15.9 $ 22.4 $ 10.0 $ 6.5 $ 3.4 $ 4.5 $ 62.7 Separated distributors 0.1 1.1 1.6 1.5 2.0 4.0 10.3 Total Franchisee Notes $ 16.0 $ 23.5 $ 11.6 $ 8.0 $ 5.4 $ 8.5 $ 73.0
Financing Receivable, Past Due	PSAs are considered past due when a contractual payment has not been made. If a customer is making payments on its account, interest will continue to accrue. The table below sets forth the aging of the Company’s PSA balances: ($ in millions) 30-59 days past due 60-90 days past due Greater than 90 days past due Total past due Total not considered past due Total Greater than 90 days past due and accruing interest September 25, 2020 $ 3.1 $ 1.6 $ 6.7 $ 11.4 $ 307.6 $ 319.0 $ 6.7 December 31, 2019 3.7 1.9 7.2 12.8 314.7 327.5 7.2
Financing Receivable, Allowance for Credit Loss	The following is a rollforward of the PSAs and Franchisee Notes components of the Company’s allowances for credit losses related to financing receivables as of September 25, 2020 and December 31, 2019: September 25, 2020 December 31, 2019 ($ in millions) PSAs Franchisee Notes Total PSAs Franchisee Notes Total Balance at beginning of year $ 29.4 $ 11.9 $ 41.3 $ 29.6 $ 14.2 $ 43.8 Transition adjustment 17.5 1.0 18.5 — — — Provision for doubtful accounts 22.1 5.0 27.1 26.4 4.5 30.9 Write-offs (25.7) (5.3) (31.0) (28.2) (7.2) (35.4) Recoveries of amounts previously charged off 2.1 0.1 2.2 1.6 0.4 2.0 Balances at end of period $ 45.4 $ 12.7 $ 58.1 $ 29.4 $ 11.9 $ 41.3
Accounts Receivable, Allowance for Credit Loss	The following is a rollforward of the allowance for credit losses related to the Company’s trade accounts receivables (excluding financing receivables) and the Company’s trade accounts receivable cost basis as of September 25, 2020: ($ in millions) Cost basis of trade accounts receivable at September 25, 2020 $ 359.7 Allowance for credit losses balance at December 31, 2019 15.0 Adoption of new accounting standard 3.6 Provision for credit losses 6.6 Write-offs (6.3) FX and other 0.1 Allowance for credit losses balance at September 25, 2020 19.0 Net trade accounts receivable balance at September 25, 2020 $ 340.7

Goodwill (Tables)

Goodwill (Tables)	9 Months Ended
	Sep. 25, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following is a rollforward of our carrying value of goodwill ($ in millions): Balance, December 31, 2019 $ 1,157.8 Impairment charge (85.3) FX translation & other (13.8) Balance, September 25, 2020 $ 1,058.7

Financing (Tables)

Financing (Tables)	9 Months Ended
	Sep. 25, 2020
Debt Disclosure [Abstract]
Schedule of Debt	The carrying values of the components of our long-term debt were as follows: ($ in millions) September 25, 2020 December 31, 2019 Short-term borrowings: 7.00% Credit Facility due in January 2020 $ — $ 12.6 6.95% Credit Facility due October 2020 12.2 — Other short-term borrowings and bank overdrafts 0.7 4.2 Total short-term borrowings $ 12.9 $ 16.8 Long-term debt: Related-party loans with Fortive entities — 24.6 Long-term debt $ — $ 24.6

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	9 Months Ended
	Sep. 25, 2020
Equity [Abstract]
Reclassification of Accumulated Other Comprehensive Income (Loss)	The changes in accumulated other comprehensive income (loss) by component are summarized below: ($ in millions) Foreign Other adjustments (b) Total For the Three Months Ended September 25, 2020: Balance, June 26, 2020 $ 126.1 $ (3.2) $ 122.9 Other comprehensive income (loss) before reclassifications, net of income taxes 14.3 — 14.3 Amounts reclassified from accumulated other comprehensive income: Increase — 0.1 0.1 Amounts reclassified from accumulated other comprehensive income, net of income taxes — 0.1 (a) 0.1 Net current period other comprehensive income (loss), net of income taxes 14.3 0.1 14.4 Balance, September 25, 2020 $ 140.4 $ (3.1) $ 137.3 For the Three Months Ended September 27, 2019: Balance, June 28, 2019 $ 137.0 $ (4.8) $ 132.2 Other comprehensive income (loss) before reclassifications, net of income taxes (15.8) (0.2) (16.0) Amounts reclassified from accumulated other comprehensive income: Increase — 0.4 0.4 Income tax impact — (0.1) (0.1) Amounts reclassified from accumulated other comprehensive income, net of income taxes — 0.3 (a) 0.3 Net current period other comprehensive income (loss), net of income taxes (15.8) 0.1 (15.7) Balance, September 27, 2019 $ 121.2 $ (4.7) $ 116.5 (a) This accumulated other comprehensive income component is included in the computation of net periodic pension cost. (b) Includes balances relating to defined benefit plans, supplemental executive retirement plans and other postretirement employee benefit plans. ($ in millions) Foreign Other adjustments (b) Total For the Nine Months Ended September 25, 2020: Balance, December 31, 2019 $ 153.7 $ (5.0) $ 148.7 Other comprehensive income (loss) before reclassifications, net of income taxes (13.3) — (13.3) Amounts reclassified from accumulated other comprehensive income: Increase — 2.0 2.0 Income tax impact — (0.1) (0.1) Amounts reclassified from accumulated other comprehensive income, net of income taxes — 1.9 (a) 1.9 Net current period other comprehensive income (loss), net of income taxes (13.3) 1.9 (11.4) Balance, September 25, 2020 $ 140.4 $ (3.1) $ 137.3 For the Nine Months Ended September 27, 2019: Balance, December 31, 2018 $ 131.3 $ (5.0) $ 126.3 Other comprehensive income (loss) before reclassifications, net of income taxes (10.1) (0.2) (10.3) Amounts reclassified from accumulated other comprehensive income: Increase — 0.6 0.6 Income tax impact — (0.1) (0.1) Amounts reclassified from accumulated other comprehensive income, net of income taxes — 0.5 (a) 0.5 Net current period other comprehensive income (loss), net of income taxes (10.1) 0.3 (9.8) Balance, September 27, 2019 $ 121.2 $ (4.7) $ 116.5 (a) This accumulated other comprehensive income component is included in the computation of net periodic pension cost. (b) Includes balances relating to defined benefit plans, supplemental executive retirement plans and other postretirement employee benefit plans.

Sales (Tables)

Sales (Tables)	9 Months Ended
	Sep. 25, 2020
Revenue from Contract with Customer [Abstract]
Contract liabilities	The Company’s contract liabilities consisted of the following: ($ in millions) September 25, 2020 December 31, 2019 Deferred revenue - current $ 85.1 $ 87.0 Deferred revenue - noncurrent 57.9 63.2 Total contract liabilities $ 143.0 $ 150.2
Disaggregation of revenue	Disaggregation of revenue for the three months ended September 25, 2020 and September 27, 2019 were as follows: ($ in millions) September 25, 2020 September 27, 2019 Sales: Sales of products $ 686.0 $ 639.7 Sales of services 60.7 74.7 Total $ 746.7 $ 714.4 Geographic: North America (a) $ 539.9 $ 494.0 Western Europe 63.7 65.8 High growth markets 111.7 124.7 Rest of world 31.4 29.9 Total $ 746.7 $ 714.4 Major Product Group: Mobility technologies $ 578.6 $ 551.6 Diagnostics and repair technologies 168.1 162.8 Total $ 746.7 $ 714.4 (a) Includes sales in the United States of $525.5 million and $477.5 million for the three months ended September 25, 2020 and September 27, 2019, respectively. Disaggregation of revenue for the nine months ended September 25, 2020 and September 27, 2019 were as follows: ($ in millions) September 25, 2020 September 27, 2019 Sales: Sales of products $ 1,713.9 $ 1,813.0 Sales of services 175.7 215.8 Total $ 1,889.6 $ 2,028.8 Geographic: North America (a) $ 1,348.3 $ 1,369.5 Western Europe 176.6 204.8 High growth markets 279.5 364.6 Rest of World 85.2 89.9 Total $ 1,889.6 $ 2,028.8 Major Product Group: Mobility technologies $ 1,441.6 $ 1,542.8 Diagnostics and repair technologies 448.0 486.0 Total $ 1,889.6 $ 2,028.8 (a) Includes sales in the United States of $1,309.2 million and $1,321.3 million for the nine months ended September 25, 2020 and September 27, 2019, respectively.

Litigation and Contingencies (T

Litigation and Contingencies (Tables)	9 Months Ended
	Sep. 25, 2020
Commitments and Contingencies Disclosure [Abstract]
Schedule of Accrued Warranty Liability	The following is a rollforward of the Company’s accrued warranty liability ($ in millions): Balance, December 31, 2019 $ 57.4 Accruals for warranties issued during the period 27.7 Settlements made (32.3) Effect of foreign currency translation (0.1) Balance, September 25, 2020 $ 52.7

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 25, 2020
Fair Value Disclosures [Abstract]
Fair Value, Liabilities Measured on Recurring Basis	Below is a summary of financial liabilities that are measured at fair value on a recurring basis: ($ in millions) Quoted Prices Significant Other Significant Total September 25, 2020 Deferred compensation liabilities $ — $ 15.6 $ — $ 15.6 December 31, 2019 Deferred compensation liabilities $ — $ 14.7 $ — $ 14.7

Related Party Transactions (Tab

Related Party Transactions (Tables)	9 Months Ended
	Sep. 25, 2020
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	The amount of related party expenses allocated to the Company from Fortive and its subsidiaries for the three and nine months ended September 25, 2020 and September 27, 2019, were as follows: Three Months Ended Nine Months Ended ($ in millions) September 25, 2020 September 27, 2019 September 25, 2020 September 27, 2019 Allocated corporate expenses $ 9.5 $ 6.7 $ 28.0 $ 20.2 Directly attributable expenses Insurance programs expenses 0.9 0.6 2.2 1.8 Medical insurance programs expenses 9.1 10.6 31.4 31.8 Deferred compensation program expenses 0.3 0.2 0.9 0.7 Total related party expenses $ 19.8 $ 18.1 $ 62.5 $ 54.5

Business Overview and Basis o_3

Business Overview and Basis of Presentation (Details) $ in Millions	Oct. 09, 2020	Sep. 28, 2020shares	Sep. 25, 2020USD ($)segmentshares	Dec. 31, 2019USD ($)shares
Class of Stock [Line Items]
Number of reportable segments | segment			1
Number of operating segments | segment			2
Common stock, outstanding (in shares) | shares			1,000	1,000
Decrease in long term financing receivable, less allowance for credit loss			$ (243.5)	$ (259)
Revision of Prior Period, Reclassification, Adjustment
Class of Stock [Line Items]
Decrease in long term financing receivable, less allowance for credit loss			3.5
Other assets			$ 3.5
Subsequent Event
Class of Stock [Line Items]
Number of shares recapitalized (in shares) | shares		168,378,946
Subsequent Event | Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations, Spinoff | Vontier | Fortive
Class of Stock [Line Items]
Spinoff transaction, percentage of outstanding common stock distributed (as a percent)	80.10%

Financing Receivables - Schedul

Financing Receivables - Schedule of Financing Receivables (Details) - USD ($) $ in Millions	Sep. 25, 2020	Dec. 31, 2019
Financing Receivable, after Allowance for Credit Loss, Current [Abstract]
Current financing receivables, gross	$ 112.5	$ 120.3
Total allowance for credit losses	22.1	17.2
Total current financing receivables, net	90.4	103.1
Financing Receivable, after Allowance for Credit Loss, Noncurrent [Abstract]
Long-term financing receivables, gross	279.5	283.1
Total allowance for credit losses	36	24.1
Total long-term financing receivables, net	243.5	259
PSAs
Financing Receivable, after Allowance for Credit Loss, Current [Abstract]
Current financing receivables, gross	97.7	104.6
Total allowance for credit losses	15	10
Total current financing receivables, net	82.7	94.6
Financing Receivable, after Allowance for Credit Loss, Noncurrent [Abstract]
Long-term financing receivables, gross	221.3	222.9
Total allowance for credit losses	30.4	19.4
Total long-term financing receivables, net	190.9	203.5
Franchisee Notes
Financing Receivable, after Allowance for Credit Loss, Current [Abstract]
Current financing receivables, gross	14.8	15.7
Total allowance for credit losses	7.1	7.2
Total current financing receivables, net	7.7	8.5
Financing Receivable, after Allowance for Credit Loss, Noncurrent [Abstract]
Long-term financing receivables, gross	58.2	60.2
Total allowance for credit losses	5.6	4.7
Total long-term financing receivables, net	$ 52.6	$ 55.5

Financing Receivables - Narrati

Financing Receivables - Narrative (Details) - USD ($) $ in Millions	Jan. 01, 2020	Sep. 25, 2020	Jun. 26, 2020	Mar. 27, 2020	Dec. 31, 2019	Sep. 27, 2019	Jun. 28, 2019	Mar. 29, 2019	Dec. 31, 2018
Financing Receivable, Allowance for Credit Loss [Line Items]
Net unamortized discount on financing receivable		$ 18.6			$ 19.3
Accounting Standards Update [Extensible List]	us-gaap:AccountingStandardsUpdate201613Member
Adjustment for new accounting standards		(1,587.4)			(1,816.1)
Financing receivable, allowance for credit loss		58.1			41.3				$ 43.8
Financing receivable, allowance for credit loss, current		22.1			17.2
Financing receivable, allowance for credit losses		$ 36			24.1
PSAs
Financing Receivable, Allowance for Credit Loss [Line Items]
Financing receivable, period for uncollectible status		180 days
Financing receivable, allowance for credit loss		$ 45.4			29.4				29.6
Financing receivable, allowance for credit loss, current		15			10
Financing receivable, allowance for credit losses		$ 30.4			19.4
Franchisee Notes
Financing Receivable, Allowance for Credit Loss [Line Items]
Financing receivable, period for uncollectible status		1 year
Financing receivable, allowance for credit loss		$ 12.7			11.9				14.2
Financing receivable, allowance for credit loss, current		7.1			7.2
Financing receivable, allowance for credit losses		5.6			4.7
Net Parent Investment
Financing Receivable, Allowance for Credit Loss [Line Items]
Adjustment for new accounting standards		$ (1,445.8)	$ (1,535.4)	$ (1,630.9)	(1,662.5)	$ (1,554.7)	$ (1,701.4)	$ (1,695.6)	(1,663.5)
Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for trade accounts and financing receivables	$ 22.1
Financing receivable, allowance for credit loss					18.5				0
Cumulative Effect, Period of Adoption, Adjustment | PSAs
Financing Receivable, Allowance for Credit Loss [Line Items]
Financing receivable, allowance for credit loss					17.5				0
Cumulative Effect, Period of Adoption, Adjustment | Franchisee Notes
Financing Receivable, Allowance for Credit Loss [Line Items]
Financing receivable, allowance for credit loss					1				$ 0
Cumulative Effect, Period of Adoption, Adjustment | Net Parent Investment
Financing Receivable, Allowance for Credit Loss [Line Items]
Adjustment for new accounting standards	$ 16.9				$ 16.9

Financing Receivables - Sched_2

Financing Receivables - Schedule of Amortized Cost by Origination Year (Details) - USD ($) $ in Millions	Sep. 25, 2020	Dec. 31, 2019
PSAs
Financing Receivable, Credit Quality Indicator [Line Items]
2020	$ 136.5
2019	99
2018	51.5
2017	22.6
2016	7.3
Prior	2.1
Total	319	$ 327.5
PSAs | Less than 400
Financing Receivable, Credit Quality Indicator [Line Items]
2020	14.1
2019	12
2018	5.6
2017	2.6
2016	0.8
Prior	0.4
Total	35.5
PSAs | 400-599
Financing Receivable, Credit Quality Indicator [Line Items]
2020	20.6
2019	15.9
2018	8.6
2017	3.8
2016	1.3
Prior	0.6
Total	50.8
PSAs | 600-799
Financing Receivable, Credit Quality Indicator [Line Items]
2020	42.2
2019	30.5
2018	16.1
2017	7.6
2016	2.8
Prior	0.7
Total	99.9
PSAs | 800+
Financing Receivable, Credit Quality Indicator [Line Items]
2020	59.6
2019	40.6
2018	21.2
2017	8.6
2016	2.4
Prior	0.4
Total	132.8
Franchisee Notes
Financing Receivable, Credit Quality Indicator [Line Items]
2020	16
2019	23.5
2018	11.6
2017	8
2016	5.4
Prior	8.5
Total	73
Franchisee Notes | Active distributors
Financing Receivable, Credit Quality Indicator [Line Items]
2020	15.9
2019	22.4
2018	10
2017	6.5
2016	3.4
Prior	4.5
Total	62.7
Franchisee Notes | Separated distributors
Financing Receivable, Credit Quality Indicator [Line Items]
2020	0.1
2019	1.1
2018	1.6
2017	1.5
2016	2
Prior	4
Total	$ 10.3

Financing Receivables - Sched_3

Financing Receivables - Schedule of Financing Receivable Past Due (Details) - PSAs - USD ($) $ in Millions	Sep. 25, 2020	Dec. 31, 2019
Financing Receivable, Past Due [Line Items]
Past due financing receivables	$ 11.4	$ 12.8
Total not considered past due	307.6	314.7
Total	319	327.5
Greater than 90 days past due and accruing interest	6.7	7.2
30-59 days past due
Financing Receivable, Past Due [Line Items]
Past due financing receivables	3.1	3.7
60-90 days past due
Financing Receivable, Past Due [Line Items]
Past due financing receivables	1.6	1.9
Greater than 90 days past due
Financing Receivable, Past Due [Line Items]
Past due financing receivables	$ 6.7	$ 7.2

Financing Receivables - Sched_4

Financing Receivables - Schedule Of Allowance For Credit Losses (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 25, 2020	Dec. 31, 2019
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance at beginning of year	$ 41.3	$ 43.8
Provision for doubtful accounts	27.1	30.9
Write-offs	(31)	(35.4)
Recoveries of amounts previously charged off	2.2	2
Balances at end of period	58.1	41.3
Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance at beginning of year	18.5	0
Balances at end of period		18.5
PSAs
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance at beginning of year	29.4	29.6
Provision for doubtful accounts	22.1	26.4
Write-offs	(25.7)	(28.2)
Recoveries of amounts previously charged off	2.1	1.6
Balances at end of period	45.4	29.4
PSAs | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance at beginning of year	17.5	0
Balances at end of period		17.5
Franchisee Notes
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance at beginning of year	11.9	14.2
Provision for doubtful accounts	5	4.5
Write-offs	(5.3)	(7.2)
Recoveries of amounts previously charged off	0.1	0.4
Balances at end of period	12.7	11.9
Franchisee Notes | Cumulative Effect, Period of Adoption, Adjustment
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Balance at beginning of year	$ 1	0
Balances at end of period		$ 1

Financing Receivable - Allowanc

Financing Receivable - Allowance For Credit Losses Related To Trade Accounts Receivable (Details) $ in Millions	9 Months Ended
	Sep. 25, 2020USD ($)
Financing Receivable, Allowance for Credit Loss [Line Items]
Cost basis of trade accounts receivable at September 25, 2020	$ 359.7
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses balance at December 31, 2019	15
Provision for credit losses	6.6
Write-offs	(6.3)
FX and other	0.1
Allowance for credit losses balance at September 25, 2020	19
Net trade accounts receivable balance at September 25, 2020	340.7
Cumulative Effect, Period of Adoption, Adjustment
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses balance at December 31, 2019	$ 3.6

Goodwill - Rollforward of Goodw

Goodwill - Rollforward of Goodwill (Details) - USD ($) $ in Millions	3 Months Ended			9 Months Ended
	Sep. 25, 2020	Mar. 27, 2020	Sep. 27, 2019	Sep. 25, 2020	Sep. 27, 2019
Goodwill [Roll Forward]
Beginning balance		$ 1,157.8		$ 1,157.8
Impairment charge	$ 0	(85.3)	$ 0	(85.3)	$ 0
Foreign currency translation & other				(13.8)
Ending balance	$ 1,058.7	$ 238.8		$ 1,058.7

Goodwill - Narrative (Details)

Goodwill - Narrative (Details) $ in Millions	Mar. 27, 2020USD ($)	Sep. 25, 2020USD ($)	Mar. 27, 2020USD ($)	Sep. 27, 2019USD ($)	Sep. 25, 2020USD ($)	Sep. 27, 2019USD ($)	Dec. 31, 2019USD ($)reporting_unit
Goodwill [Line Items]
Number of reporting units | reporting_unit							5
Impairment of goodwill		$ 0	$ 85.3	$ 0	$ 85.3	$ 0
Goodwill	$ 238.8	$ 1,058.7	$ 238.8		$ 1,058.7		$ 1,157.8
Telematics
Goodwill [Line Items]
Percentage of fair value in excess of carrying amount (as a percent)							5.00%
Impairment of goodwill	$ 85.3

Financing - Components of Debt

Financing - Components of Debt (Details) - USD ($) $ in Millions	Sep. 25, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Total short-term borrowings	$ 12.9	$ 16.8
Long-term debt	0	24.6
7.00% Credit Facility due in January 2020
Debt Instrument [Line Items]
Total short-term borrowings	$ 0	12.6
Interest rate, stated percentage	7.00%
6.95% Credit Facility due October 2020
Debt Instrument [Line Items]
Total short-term borrowings	$ 12.2	0
Interest rate, stated percentage	6.95%
Other short-term borrowings and bank overdrafts
Debt Instrument [Line Items]
Total short-term borrowings	$ 0.7	4.2
Related-party loans with Fortive entities
Debt Instrument [Line Items]
Long-term debt	$ 0	$ 24.6

Financing - Narrative (Details)

Financing - Narrative (Details) - USD ($) $ in Millions	Oct. 03, 2020	Sep. 25, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Short term debt renewed		$ 12.9	$ 16.8
Other short-term borrowings and bank overdrafts
Debt Instrument [Line Items]
Interest rate at the end of the period (as a percent)		7.20%	9.00%
Short term debt renewed		$ 0.7	$ 4.2
6.95% Credit Facility due October 2020
Debt Instrument [Line Items]
Interest rate, stated percentage		6.95%
Short term debt renewed		$ 12.2	$ 0
6.95% Credit Facility due October 2020 | Subsequent Event
Debt Instrument [Line Items]
Interest rate, stated percentage	5.95%
Short term debt renewed	$ 10.9
6.70% Credit Facility due July 2020
Debt Instrument [Line Items]
Interest rate, stated percentage		6.70%
Related-party loans with Fortive entities
Debt Instrument [Line Items]
Interest rate at the end of the period (as a percent)			1.00%

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Sep. 25, 2020	Jun. 26, 2020	Mar. 27, 2020	Sep. 27, 2019	Jun. 28, 2019	Mar. 29, 2019	Sep. 25, 2020	Sep. 27, 2019
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance			$ 1,816.1				$ 1,816.1
Other comprehensive income (loss) before reclassifications, net of income taxes	$ 14.3			$ (16)			(13.3)	$ (10.3)
Amounts reclassified from accumulated other comprehensive income (loss):
Increase	0.1			0.4			2	0.6
Income tax impact				(0.1)			(0.1)	(0.1)
Amounts reclassified from accumulated other comprehensive income, net of income taxes	0.1			0.3			1.9	0.5
Net current period other comprehensive income (loss), net of income taxes	14.4			(15.7)			(11.4)	(9.8)
Ending balance	1,587.4						1,587.4
Foreign currency translation adjustments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	126.1		153.7	137		$ 131.3	153.7	131.3
Other comprehensive income (loss) before reclassifications, net of income taxes	14.3			(15.8)			(13.3)	(10.1)
Amounts reclassified from accumulated other comprehensive income (loss):
Increase	0			0			0	0
Income tax impact				0			0	0
Amounts reclassified from accumulated other comprehensive income, net of income taxes	0			0			0	0
Net current period other comprehensive income (loss), net of income taxes	14.3			(15.8)			(13.3)	(10.1)
Ending balance	140.4	$ 126.1		121.2	$ 137		140.4	121.2
Other adjustments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(3.2)		(5)	(4.8)		(5)	(5)	(5)
Other comprehensive income (loss) before reclassifications, net of income taxes	0			(0.2)			0	(0.2)
Amounts reclassified from accumulated other comprehensive income (loss):
Increase	0.1			0.4			2	0.6
Income tax impact				(0.1)			(0.1)	(0.1)
Amounts reclassified from accumulated other comprehensive income, net of income taxes	0.1			0.3			1.9	0.5
Net current period other comprehensive income (loss), net of income taxes	0.1			0.1			1.9	0.3
Ending balance	(3.1)	(3.2)		(4.7)	(4.8)		(3.1)	(4.7)
Total
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	122.9	104.2	148.7	132.2	128.9	126.3	148.7	126.3
Amounts reclassified from accumulated other comprehensive income (loss):
Net current period other comprehensive income (loss), net of income taxes	14.4	18.7	(44.5)	(15.7)	3.3	2.6
Ending balance	$ 137.3	$ 122.9	$ 104.2	$ 116.5	$ 132.2	$ 128.9	$ 137.3	$ 116.5

Sales - Contract Assets and Cos

Sales - Contract Assets and Costs (Details) - USD ($) $ in Millions	Sep. 25, 2020	Dec. 31, 2019
Capitalized Contract Cost [Line Items]
Contract assets	$ 11.7	$ 12.8
Minimum
Capitalized Contract Cost [Line Items]
Useful life	3 years
Maximum
Capitalized Contract Cost [Line Items]
Useful life	5 years
Deferred Sales Commissions
Capitalized Contract Cost [Line Items]
Net revenue-related contract assets	$ 81.1	$ 95.2

Sales - Contract liabilities (D

Sales - Contract liabilities (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 25, 2020	Sep. 25, 2020	Dec. 31, 2019
Revenue from Contract with Customer [Abstract]
Deferred revenue - current	$ 85.1	$ 85.1	$ 87
Deferred revenue - noncurrent	57.9	57.9	63.2
Total contract liabilities	143	143	$ 150.2
Contract liabilities, revenue recognized	$ 31.1	$ 84.8

Sales - Revenue, Remaining Perf

Sales - Revenue, Remaining Performance Obligation (Details) $ in Millions	Sep. 25, 2020USD ($)
Revenue from Contract with Customer [Abstract]
Remaining performance obligations	$ 386

Sales - Remaining Performance O

Sales - Remaining Performance Obligation, Expected Timing (Details)	Sep. 25, 2020
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-09-26
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percentage	35.00%
Remaining performance obligation, expected timing	2 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-09-30
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percentage	65.00%
Remaining performance obligation, expected timing	4 years

Sales - Disaggregation of Reven

Sales - Disaggregation of Revenue (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 25, 2020	Sep. 27, 2019	Sep. 25, 2020	Sep. 27, 2019
Disaggregation of Revenue [Line Items]
Sales	$ 746.7	$ 714.4	$ 1,889.6	$ 2,028.8
Products
Disaggregation of Revenue [Line Items]
Sales	686	639.7	1,713.9	1,813
Mobility technologies
Disaggregation of Revenue [Line Items]
Sales	578.6	551.6	1,441.6	1,542.8
Diagnostics and repair technologies
Disaggregation of Revenue [Line Items]
Sales	168.1	162.8	448	486
Services
Disaggregation of Revenue [Line Items]
Sales	60.7	74.7	175.7	215.8
North America
Disaggregation of Revenue [Line Items]
Sales	539.9	494	1,348.3	1,369.5
Western Europe
Disaggregation of Revenue [Line Items]
Sales	63.7	65.8	176.6	204.8
High growth markets
Disaggregation of Revenue [Line Items]
Sales	111.7	124.7	279.5	364.6
Rest of world
Disaggregation of Revenue [Line Items]
Sales	31.4	29.9	85.2	89.9
UNITED STATES
Disaggregation of Revenue [Line Items]
Sales	$ 525.5	$ 477.5	$ 1,309.2	$ 1,321.3

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details)	3 Months Ended		9 Months Ended
	Sep. 25, 2020	Sep. 27, 2019	Sep. 25, 2020	Sep. 27, 2019
Income Tax Disclosure [Abstract]
Effective tax rate (as a percent)	20.90%	23.20%	29.00%	23.30%

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 25, 2020	Sep. 27, 2019	Sep. 25, 2020	Sep. 27, 2019
Leases [Abstract]
Operating lease cost	$ 5.3	$ 5.6	$ 15.6	$ 16.8
Cash paid for operating leases			14.7	$ 16.9
ROU assets obtained in exchange for operating lease obligations			$ 11.5

Litigation and Contingencies -

Litigation and Contingencies - Rollforward of Accrued Warranty Liability (Details) $ in Millions	9 Months Ended
	Sep. 25, 2020USD ($)
Movement in Standard Product Warranty Accrual [Roll Forward]
Beginning balance	$ 57.4
Accruals for warranties issued during the period	27.7
Settlements made	(32.3)
Effect of foreign currency translation	(0.1)
Ending balance	$ 52.7

Litigation and Contingencies _2

Litigation and Contingencies - Narrative (Details) - USD ($)	Sep. 25, 2020	Dec. 31, 2019	Feb. 22, 2019
0.875% Convertible Senior Notes | Senior Notes | Fortive
Loss Contingencies [Line Items]
Aggregate principal amount of debt issued			$ 1,400,000,000
Interest rate, stated percentage			0.875%
Standby letters of credit, bank guarantees, and performance and bid bonds
Loss Contingencies [Line Items]
Guarantees	$ 69,300,000	$ 36,700,000
Asbestos Claims
Loss Contingencies [Line Items]
Liabilities associated with future expected cases	51,000,000	54,400,000
Projected insurance recoveries	20,300,000	24,900,000
Accrued expenses and other current liabilities | Asbestos Claims
Loss Contingencies [Line Items]
Liabilities associated with future expected cases	7,500,000	5,600,000
Other long-term liabilities | Asbestos Claims
Loss Contingencies [Line Items]
Liabilities associated with future expected cases	43,500,000	48,800,000
Prepaid expenses and other current assets | Asbestos Claims
Loss Contingencies [Line Items]
Projected insurance recoveries	3,900,000	3,900,000
Other assets | Asbestos Claims
Loss Contingencies [Line Items]
Projected insurance recoveries	$ 16,400,000	$ 21,000,000

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Millions	Mar. 27, 2020	Sep. 25, 2020	Mar. 27, 2020	Sep. 27, 2019	Sep. 25, 2020	Sep. 27, 2019	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity investment without readily determinable fair value		$ 49			$ 49
Impairment of goodwill		0	$ 85.3	$ 0	85.3	$ 0
Telematics
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impairment of goodwill	$ 85.3
Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation liabilities		15.6			15.6		$ 14.7
Fair Value, Measurements, Recurring | Quoted Prices in Active Market (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation liabilities		0			0		0
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation liabilities		15.6			15.6		14.7
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation liabilities		$ 0			$ 0		$ 0

Related Party Transactions - Sc

Related Party Transactions - Schedule of Related Party Expenses (Details) - Fortive - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 25, 2020	Sep. 27, 2019	Sep. 25, 2020	Sep. 27, 2019
Related Party Transaction [Line Items]
Total related party expenses	$ 19.8	$ 18.1	$ 62.5	$ 54.5
Allocated corporate expenses
Related Party Transaction [Line Items]
Total related party expenses	9.5	6.7	28	20.2
Insurance programs expenses
Related Party Transaction [Line Items]
Total related party expenses	0.9	0.6	2.2	1.8
Medical insurance programs expenses
Related Party Transaction [Line Items]
Total related party expenses	9.1	10.6	31.4	31.8
Deferred compensation program expenses
Related Party Transaction [Line Items]
Total related party expenses	$ 0.3	$ 0.2	$ 0.9	$ 0.7

Related Party Transactions - Na

Related Party Transactions - Narrative (Details) - Fortive - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 25, 2020	Sep. 27, 2019	Sep. 25, 2020	Sep. 27, 2019	Dec. 31, 2019
Related Party Transaction [Line Items]
Purchases from related party	$ 4	$ 5.1	$ 11.9	$ 11.5
Related-party loans with Fortive entities
Related Party Transaction [Line Items]
Loans due to Fortive entities					$ 24.6
Interest income on related party transactions		$ 3.1		$ 6.5

Capitalization and Earnings P_2

Capitalization and Earnings Per Share (Details) - $ / shares	Oct. 09, 2020	Sep. 28, 2020	Aug. 05, 2019	Sep. 25, 2020	Dec. 31, 2019
Class of Stock [Line Items]
Common stock, authorized (in shares)				1,985,000,000	1,000
Common stock, par value (in dollars per share)				$ 0.0001	$ 0.0001
Preferred stock, authorized (in shares)				15,000,000	15,000,000
Preferred stock, par value (in dollars per share)				$ 0	$ 0
Shares issued during period			1,000
Subsequent Event
Class of Stock [Line Items]
Common stock converted (in shares)		168,378.946
Number of shares recapitalized (in shares)		168,378,946
Subsequent Event | Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations, Spinoff | Vontier | Fortive
Class of Stock [Line Items]
Spinoff transaction, ownership percentage after transaction (as a percent)	19.90%
Spinoff transaction, percentage of outstanding common stock distributed (as a percent)	80.10%

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event	Oct. 09, 2020USD ($)	Sep. 29, 2020USD ($)
Subsequent Event [Line Items]
Cash and equivalents	$ 287,900,000
Fortive | Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations, Spinoff | Vontier
Subsequent Event [Line Items]
Spinoff transaction, percentage of outstanding common stock distributed (as a percent)	80.10%
Shares of Vontier converted into shares of Fortive (in shares)	2.5
Spinoff transaction, ownership percentage after transaction (as a percent)	19.90%
Fortive | Consideration For Contribution of Certain Assets and Liabilities
Subsequent Event [Line Items]
Payments of expenses to related party	$ 1,600,000,000
Fortive | Payment For Adjustment For Excess Cash Balances
Subsequent Event [Line Items]
Payments of expenses to related party	200,000,000
Fortive | Fortive Separation Agreement
Subsequent Event [Line Items]
Payable to Fortive within 90 days	84,100,000
Credit Agreement
Subsequent Event [Line Items]
Amount drawn on facility		$ 0
Covenant, consolidated leverage ratio, maximum		3.75
Covenant, consolidated leverage ratio, increase in connection with acquisition		4.25
Covenant, increase in consolidated leverage ratio, incurrence of indebtedness, amount		$ 100,000,000
Covenant, consolidated interest coverage ratio, minimum		3.50
Credit Agreement | London Interbank Offered Rate (LIBOR) | Minimum
Subsequent Event [Line Items]
Basis spread on variable rate (as a percent)		1.25%
Credit Agreement | London Interbank Offered Rate (LIBOR) | Maximum
Subsequent Event [Line Items]
Basis spread on variable rate (as a percent)		2.00%
Credit Agreement | Federal Funds Rate
Subsequent Event [Line Items]
Basis spread on variable rate (as a percent)		0.50%
Credit Agreement | Eurocurrency Rate
Subsequent Event [Line Items]
Basis spread on variable rate (as a percent)		1.00%
Credit Agreement | Eurocurrency Rate | Minimum
Subsequent Event [Line Items]
Basis spread on variable rate (as a percent)		0.25%
Credit Agreement | Eurocurrency Rate | Maximum
Subsequent Event [Line Items]
Basis spread on variable rate (as a percent)		1.00%
Credit Agreement - Eurocurrency Rate Loans
Subsequent Event [Line Items]
Minimum interest rate (as a percent)		0.00%
Credit Agreement - Base Rate Loans
Subsequent Event [Line Items]
Minimum interest rate (as a percent)		1.00%
Term Loans
Subsequent Event [Line Items]
Amount drawn on facility	$ 1,800,000,000
The Three Year Term Loans | Line of Credit
Subsequent Event [Line Items]
Debt term		3 years
Line of credit facility, maximum borrowing capacity		$ 800,000,000
The Two Year Term Loans | Line of Credit
Subsequent Event [Line Items]
Debt term		2 years
Line of credit facility, maximum borrowing capacity		$ 1,000,000,000
Revolving credit facility | Line of Credit | Revolving Credit Facility
Subsequent Event [Line Items]
Debt term		3 years
Line of credit facility, maximum borrowing capacity		$ 750,000,000
Revolving credit facility | Line of Credit | Swingline Loans
Subsequent Event [Line Items]
Line of credit facility, maximum borrowing capacity		25,000,000
Revolving credit facility | Line of Credit | Letter of Credit
Subsequent Event [Line Items]
Line of credit facility, maximum borrowing capacity		$ 75,000,000